id	sid	tid	token	lemma	pos
work_myfomrpabnam7f4o57fxudm5bi	1	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	1	2	Rise	rise	NN
work_myfomrpabnam7f4o57fxudm5bi	1	3	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	1	4	Fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	1	5	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	1	6	Tuberculosis	Tuberculosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	7	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	1	8	Atherosclerosis	Atherosclerosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	9	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	1	10	First	first	RB
work_myfomrpabnam7f4o57fxudm5bi	1	11	There	there	EX
work_myfomrpabnam7f4o57fxudm5bi	1	12	Is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	1	13	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	1	14	Mountain&hellip	Mountain&hellip	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	15	;	;	:
work_myfomrpabnam7f4o57fxudm5bi	1	16	Editorial	Editorial	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	17	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	1	18	Rise	Rise	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	19	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	1	20	Fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	1	21	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	1	22	Tuberculosis	Tuberculosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	23	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	1	24	Atherosclerosis	Atherosclerosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	25	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	1	26	First	first	RB
work_myfomrpabnam7f4o57fxudm5bi	1	27	There	there	EX
work_myfomrpabnam7f4o57fxudm5bi	1	28	Is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	1	29	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	1	30	Mountain	Mountain	NNP
work_myfomrpabnam7f4o57fxudm5bi	1	31	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	2	1	David	David	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	2	D.	D.	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	3	Waters	Waters	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	4	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	5	MD	MD	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	6	Division	Division	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	7	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	2	8	Cardiology	Cardiology	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	10	San	San	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	11	Francisco	Francisco	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	12	General	General	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	13	Hospital	Hospital	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	14	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	15	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	2	16	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	2	17	Department	Department	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	18	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	2	19	Medicine	Medicine	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	20	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	21	University	University	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	22	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	2	23	California	California	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	24	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	25	San	San	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	26	Francisco	Francisco	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	27	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	28	San	San	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	29	Francisco	Francisco	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	30	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	31	California	California	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	32	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	33	USA	USA	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	34	See	see	VB
work_myfomrpabnam7f4o57fxudm5bi	2	35	article	article	NN
work_myfomrpabnam7f4o57fxudm5bi	2	36	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	2	37	Tu	Tu	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	38	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	39	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	40	.	.	NNP
work_myfomrpabnam7f4o57fxudm5bi	2	41	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	2	42	pages	page	NNS
work_myfomrpabnam7f4o57fxudm5bi	2	43	378e384	378e384	CD
work_myfomrpabnam7f4o57fxudm5bi	2	44	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	2	45	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	2	46	issue	issue	NN
work_myfomrpabnam7f4o57fxudm5bi	2	47	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	3	1	First	first	RB
work_myfomrpabnam7f4o57fxudm5bi	3	2	there	there	EX
work_myfomrpabnam7f4o57fxudm5bi	3	3	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	3	4	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	3	5	mountain	mountain	NN
work_myfomrpabnam7f4o57fxudm5bi	3	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	3	7	then	then	RB
work_myfomrpabnam7f4o57fxudm5bi	3	8	there	there	EX
work_myfomrpabnam7f4o57fxudm5bi	3	9	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	3	10	no	no	DT
work_myfomrpabnam7f4o57fxudm5bi	3	11	mountain	mountain	NN
work_myfomrpabnam7f4o57fxudm5bi	3	12	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	3	13	then	then	RB
work_myfomrpabnam7f4o57fxudm5bi	3	14	there	there	EX
work_myfomrpabnam7f4o57fxudm5bi	3	15	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	3	16	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	4	1	eZen	eZen	VBN
work_myfomrpabnam7f4o57fxudm5bi	4	2	proverb	proverb	NN
work_myfomrpabnam7f4o57fxudm5bi	4	3	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	4	4	song	song	NN
work_myfomrpabnam7f4o57fxudm5bi	4	5	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	4	6	Donavan	Donavan	NNP
work_myfomrpabnam7f4o57fxudm5bi	4	7	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	4	8	British	british	JJ
work_myfomrpabnam7f4o57fxudm5bi	4	9	singer	singer	NN
work_myfomrpabnam7f4o57fxudm5bi	4	10	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	4	11	1968	1968	CD
work_myfomrpabnam7f4o57fxudm5bi	4	12	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	4	13	By	by	IN
work_myfomrpabnam7f4o57fxudm5bi	4	14	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	4	15	beginning	beginning	NN
work_myfomrpabnam7f4o57fxudm5bi	4	16	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	4	17	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	4	18	19th	19th	JJ
work_myfomrpabnam7f4o57fxudm5bi	4	19	century	century	NN
work_myfomrpabnam7f4o57fxudm5bi	4	20	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	4	21	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	4	22	had	have	VBD
work_myfomrpabnam7f4o57fxudm5bi	4	23	killed	kill	VBN
work_myfomrpabnam7f4o57fxudm5bi	4	24	1	1	CD
work_myfomrpabnam7f4o57fxudm5bi	4	25	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	4	26	7	7	CD
work_myfomrpabnam7f4o57fxudm5bi	4	27	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	4	28	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	4	29	individuals	individual	NNS
work_myfomrpabnam7f4o57fxudm5bi	4	30	who	who	WP
work_myfomrpabnam7f4o57fxudm5bi	4	31	had	have	VBD
work_myfomrpabnam7f4o57fxudm5bi	4	32	ever	ever	RB
work_myfomrpabnam7f4o57fxudm5bi	4	33	lived	live	VBN
work_myfomrpabnam7f4o57fxudm5bi	4	34	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	5	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	5	2	Europe	Europe	NNP
work_myfomrpabnam7f4o57fxudm5bi	5	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	5	4	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	5	5	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	5	6	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	5	7	began	begin	VBD
work_myfomrpabnam7f4o57fxudm5bi	5	8	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	5	9	rise	rise	VB
work_myfomrpabnam7f4o57fxudm5bi	5	10	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	5	11	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	5	12	early	early	JJ
work_myfomrpabnam7f4o57fxudm5bi	5	13	17th	17th	JJ
work_myfomrpabnam7f4o57fxudm5bi	5	14	century	century	NN
work_myfomrpabnam7f4o57fxudm5bi	5	15	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	5	16	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	5	17	peak	peak	NN
work_myfomrpabnam7f4o57fxudm5bi	5	18	level	level	NN
work_myfomrpabnam7f4o57fxudm5bi	5	19	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	5	20	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	5	21	19th	19th	JJ
work_myfomrpabnam7f4o57fxudm5bi	5	22	century	century	NN
work_myfomrpabnam7f4o57fxudm5bi	5	23	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	5	24	when	when	WRB
work_myfomrpabnam7f4o57fxudm5bi	5	25	it	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	5	26	caused	cause	VBD
work_myfomrpabnam7f4o57fxudm5bi	5	27	nearly	nearly	RB
work_myfomrpabnam7f4o57fxudm5bi	5	28	25	25	CD
work_myfomrpabnam7f4o57fxudm5bi	5	29	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	5	30	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	5	31	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	5	32	deaths	death	NNS
work_myfomrpabnam7f4o57fxudm5bi	5	33	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	6	1	Among	among	IN
work_myfomrpabnam7f4o57fxudm5bi	6	2	writers	writer	NNS
work_myfomrpabnam7f4o57fxudm5bi	6	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	4	Jane	Jane	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	5	Austen	Austen	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	6	8	Brontë	Brontë	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	9	sisters	sister	NNS
work_myfomrpabnam7f4o57fxudm5bi	6	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	11	John	John	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	12	Keats	Keats	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	13	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	14	Elizabeth	Elizabeth	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	15	Browning	Browning	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	16	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	17	Anton	Anton	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	18	Chekhov	Chekhov	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	19	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	20	Albert	Albert	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	21	Camus	Camus	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	22	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	23	Franz	Franz	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	24	Kafka	Kafka	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	25	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	26	Henry	Henry	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	27	David	David	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	28	Thoreau	Thoreau	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	29	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	6	30	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	6	31	George	George	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	32	Orwell	Orwell	NNP
work_myfomrpabnam7f4o57fxudm5bi	6	33	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	6	34	succumbed	succumb	VBD
work_myfomrpabnam7f4o57fxudm5bi	6	35	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	7	1	Urban	urban	JJ
work_myfomrpabnam7f4o57fxudm5bi	7	2	poverty	poverty	NN
work_myfomrpabnam7f4o57fxudm5bi	7	3	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	7	4	overcrowding	overcrowding	NN
work_myfomrpabnam7f4o57fxudm5bi	7	5	were	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	7	6	strong	strong	JJ
work_myfomrpabnam7f4o57fxudm5bi	7	7	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	7	8	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	7	9	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	7	10	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	7	11	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	7	12	but	but	CC
work_myfomrpabnam7f4o57fxudm5bi	7	13	its	-PRON-	PRP$
work_myfomrpabnam7f4o57fxudm5bi	7	14	reach	reach	NN
work_myfomrpabnam7f4o57fxudm5bi	7	15	extended	extend	VBN
work_myfomrpabnam7f4o57fxudm5bi	7	16	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	7	17	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	7	18	levels	level	NNS
work_myfomrpabnam7f4o57fxudm5bi	7	19	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	7	20	society	society	NN
work_myfomrpabnam7f4o57fxudm5bi	7	21	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	8	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	8	2	what	what	WP
work_myfomrpabnam7f4o57fxudm5bi	8	3	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	8	4	generally	generally	RB
work_myfomrpabnam7f4o57fxudm5bi	8	5	considered	consider	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	6	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	8	7	be	be	VB
work_myfomrpabnam7f4o57fxudm5bi	8	8	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	8	9	first	first	JJ
work_myfomrpabnam7f4o57fxudm5bi	8	10	randomized	randomize	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	11	controlled	control	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	12	clinical	clinical	JJ
work_myfomrpabnam7f4o57fxudm5bi	8	13	trial	trial	NN
work_myfomrpabnam7f4o57fxudm5bi	8	14	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	8	15	medicine	medicine	NN
work_myfomrpabnam7f4o57fxudm5bi	8	16	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	8	17	streptomycin	streptomycin	NNP
work_myfomrpabnam7f4o57fxudm5bi	8	18	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	8	19	shown	show	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	20	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	8	21	reduce	reduce	VB
work_myfomrpabnam7f4o57fxudm5bi	8	22	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	8	23	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	8	24	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	8	25	series	series	NN
work_myfomrpabnam7f4o57fxudm5bi	8	26	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	8	27	young	young	JJ
work_myfomrpabnam7f4o57fxudm5bi	8	28	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	8	29	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	8	30	active	active	JJ
work_myfomrpabnam7f4o57fxudm5bi	8	31	pulmonary	pulmonary	NN
work_myfomrpabnam7f4o57fxudm5bi	8	32	tuberculosis.1	tuberculosis.1	RB
work_myfomrpabnam7f4o57fxudm5bi	8	33	However	however	RB
work_myfomrpabnam7f4o57fxudm5bi	8	34	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	8	35	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	8	36	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	8	37	time	time	NN
work_myfomrpabnam7f4o57fxudm5bi	8	38	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	8	39	study	study	NN
work_myfomrpabnam7f4o57fxudm5bi	8	40	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	8	41	published	publish	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	42	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	8	43	1948	1948	CD
work_myfomrpabnam7f4o57fxudm5bi	8	44	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	8	45	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	8	46	threat	threat	NN
work_myfomrpabnam7f4o57fxudm5bi	8	47	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	8	48	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	8	49	had	have	VBD
work_myfomrpabnam7f4o57fxudm5bi	8	50	largely	largely	RB
work_myfomrpabnam7f4o57fxudm5bi	8	51	receded	recede	VBN
work_myfomrpabnam7f4o57fxudm5bi	8	52	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	8	53	Europe	Europe	NNP
work_myfomrpabnam7f4o57fxudm5bi	8	54	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	8	55	North	North	NNP
work_myfomrpabnam7f4o57fxudm5bi	8	56	America	America	NNP
work_myfomrpabnam7f4o57fxudm5bi	8	57	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	9	1	A	a	DT
work_myfomrpabnam7f4o57fxudm5bi	9	2	better	well	RBR
work_myfomrpabnam7f4o57fxudm5bi	9	3	under-	under-	XX
work_myfomrpabnam7f4o57fxudm5bi	9	4	standing	standing	NN
work_myfomrpabnam7f4o57fxudm5bi	9	5	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	9	6	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	9	7	pathophysiology	pathophysiology	NN
work_myfomrpabnam7f4o57fxudm5bi	9	8	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	9	9	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	9	10	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	9	11	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	9	12	improved	improved	JJ
work_myfomrpabnam7f4o57fxudm5bi	9	13	living	living	NN
work_myfomrpabnam7f4o57fxudm5bi	9	14	conditions	condition	NNS
work_myfomrpabnam7f4o57fxudm5bi	9	15	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	9	16	better	well	JJR
work_myfomrpabnam7f4o57fxudm5bi	9	17	diagnosis	diagnosis	NN
work_myfomrpabnam7f4o57fxudm5bi	9	18	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	9	19	isolation	isolation	NN
work_myfomrpabnam7f4o57fxudm5bi	9	20	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	9	21	active	active	JJ
work_myfomrpabnam7f4o57fxudm5bi	9	22	cases	case	NNS
work_myfomrpabnam7f4o57fxudm5bi	9	23	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	9	24	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	9	25	better	well	JJR
work_myfomrpabnam7f4o57fxudm5bi	9	26	treatment	treatment	NN
work_myfomrpabnam7f4o57fxudm5bi	9	27	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	9	28	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	9	29	assumed	assume	VBN
work_myfomrpabnam7f4o57fxudm5bi	9	30	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	9	31	have	have	VB
work_myfomrpabnam7f4o57fxudm5bi	9	32	contributed	contribute	VBN
work_myfomrpabnam7f4o57fxudm5bi	9	33	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	9	34	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	9	35	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	9	36	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	9	37	tuberculosis	tuberculosis	JJ
work_myfomrpabnam7f4o57fxudm5bi	9	38	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	9	39	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	9	40	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	9	41	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	10	1	Myocardial	myocardial	JJ
work_myfomrpabnam7f4o57fxudm5bi	10	2	infarction	infarction	NN
work_myfomrpabnam7f4o57fxudm5bi	10	3	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	10	4	first	first	RB
work_myfomrpabnam7f4o57fxudm5bi	10	5	clearly	clearly	RB
work_myfomrpabnam7f4o57fxudm5bi	10	6	described	describe	VBN
work_myfomrpabnam7f4o57fxudm5bi	10	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	10	8	1912.2	1912.2	CD
work_myfomrpabnam7f4o57fxudm5bi	10	9	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	10	10	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	10	11	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	10	12	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	10	13	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	10	14	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	10	15	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	10	16	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	10	17	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	10	18	increased	increase	VBD
work_myfomrpabnam7f4o57fxudm5bi	10	19	rapidly	rapidly	RB
work_myfomrpabnam7f4o57fxudm5bi	10	20	over	over	IN
work_myfomrpabnam7f4o57fxudm5bi	10	21	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	10	22	ensuing	ensue	VBG
work_myfomrpabnam7f4o57fxudm5bi	10	23	decades	decade	NNS
work_myfomrpabnam7f4o57fxudm5bi	10	24	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	10	25	peaking	peak	VBG
work_myfomrpabnam7f4o57fxudm5bi	10	26	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	10	27	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	10	28	mid-1960s	mid-1960	NNS
work_myfomrpabnam7f4o57fxudm5bi	10	29	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	10	30	North	North	NNP
work_myfomrpabnam7f4o57fxudm5bi	10	31	America	America	NNP
work_myfomrpabnam7f4o57fxudm5bi	10	32	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	10	33	about	about	RB
work_myfomrpabnam7f4o57fxudm5bi	10	34	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	10	35	decade	decade	NN
work_myfomrpabnam7f4o57fxudm5bi	10	36	later	later	RB
work_myfomrpabnam7f4o57fxudm5bi	10	37	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	10	38	Western	Western	NNP
work_myfomrpabnam7f4o57fxudm5bi	10	39	Europe	Europe	NNP
work_myfomrpabnam7f4o57fxudm5bi	10	40	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	11	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	2	1977	1977	CD
work_myfomrpabnam7f4o57fxudm5bi	11	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	11	4	it	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	11	5	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	11	6	belatedly	belatedly	RB
work_myfomrpabnam7f4o57fxudm5bi	11	7	recognized	recognize	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	8	that	that	IN
work_myfomrpabnam7f4o57fxudm5bi	11	9	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	10	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	11	11	had	have	VBD
work_myfomrpabnam7f4o57fxudm5bi	11	12	been	be	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	13	falling	fall	VBG
work_myfomrpabnam7f4o57fxudm5bi	11	14	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	15	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	11	16	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	17	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	18	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	11	19	more	more	JJR
work_myfomrpabnam7f4o57fxudm5bi	11	20	than	than	IN
work_myfomrpabnam7f4o57fxudm5bi	11	21	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	11	22	decade	decade	NN
work_myfomrpabnam7f4o57fxudm5bi	11	23	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	11	24	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	11	25	an	an	DT
work_myfomrpabnam7f4o57fxudm5bi	11	26	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	11	27	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	11	28	adjusted	adjust	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	29	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	11	30	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	11	31	approximately	approximately	RB
work_myfomrpabnam7f4o57fxudm5bi	11	32	25	25	CD
work_myfomrpabnam7f4o57fxudm5bi	11	33	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	11	34	across	across	IN
work_myfomrpabnam7f4o57fxudm5bi	11	35	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	11	36	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	11	37	groups.3	groups.3	CD
work_myfomrpabnam7f4o57fxudm5bi	11	38	Since	since	IN
work_myfomrpabnam7f4o57fxudm5bi	11	39	then	then	RB
work_myfomrpabnam7f4o57fxudm5bi	11	40	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	11	41	both	both	CC
work_myfomrpabnam7f4o57fxudm5bi	11	42	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	11	43	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	11	44	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	11	45	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	11	46	case	case	NN
work_myfomrpabnam7f4o57fxudm5bi	11	47	fatality	fatality	NN
work_myfomrpabnam7f4o57fxudm5bi	11	48	rate	rate	NN
work_myfomrpabnam7f4o57fxudm5bi	11	49	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	11	50	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	51	have	have	VBP
work_myfomrpabnam7f4o57fxudm5bi	11	52	steadily	steadily	RB
work_myfomrpabnam7f4o57fxudm5bi	11	53	decreased	decrease	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	54	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	55	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	11	56	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	57	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	11	58	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	11	59	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	11	60	reductions	reduction	NNS
work_myfomrpabnam7f4o57fxudm5bi	11	61	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	62	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	11	63	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	11	64	adjusted	adjust	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	65	CHD	chd	NN
work_myfomrpabnam7f4o57fxudm5bi	11	66	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	11	67	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	11	68	1980	1980	CD
work_myfomrpabnam7f4o57fxudm5bi	11	69	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	11	70	2009	2009	CD
work_myfomrpabnam7f4o57fxudm5bi	11	71	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	11	72	66	66	CD
work_myfomrpabnam7f4o57fxudm5bi	11	73	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	11	74	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	75	men	man	NNS
work_myfomrpabnam7f4o57fxudm5bi	11	76	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	11	77	67	67	CD
work_myfomrpabnam7f4o57fxudm5bi	11	78	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	11	79	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	11	80	women.4	women.4	NN
work_myfomrpabnam7f4o57fxudm5bi	11	81	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	11	82	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	11	83	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	11	84	stroke	stroke	NN
work_myfomrpabnam7f4o57fxudm5bi	11	85	peaked	peak	VBD
work_myfomrpabnam7f4o57fxudm5bi	11	86	earlier	early	RBR
work_myfomrpabnam7f4o57fxudm5bi	11	87	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	11	88	has	have	VBZ
work_myfomrpabnam7f4o57fxudm5bi	11	89	shown	show	VBN
work_myfomrpabnam7f4o57fxudm5bi	11	90	similar	similar	JJ
work_myfomrpabnam7f4o57fxudm5bi	11	91	declines	decline	NNS
work_myfomrpabnam7f4o57fxudm5bi	11	92	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	12	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	12	2	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	12	3	issue	issue	NN
work_myfomrpabnam7f4o57fxudm5bi	12	4	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	12	5	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	12	6	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	7	Journal	Journal	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	8	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	12	9	Cardiology	Cardiology	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	12	11	Tu	Tu	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	12	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	13	al.5	al.5	VBP
work_myfomrpabnam7f4o57fxudm5bi	12	14	describe	describe	VB
work_myfomrpabnam7f4o57fxudm5bi	12	15	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	12	16	changes	change	NNS
work_myfomrpabnam7f4o57fxudm5bi	12	17	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	12	18	1994	1994	CD
work_myfomrpabnam7f4o57fxudm5bi	12	19	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	12	20	2014	2014	CD
work_myfomrpabnam7f4o57fxudm5bi	12	21	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	12	22	hos-	hos-	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	23	pitalization	pitalization	NN
work_myfomrpabnam7f4o57fxudm5bi	12	24	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	12	25	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	12	26	Ontario	Ontario	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	27	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	12	28	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	12	29	major	major	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	30	atherosclerotic	atherosclerotic	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	31	car-	car-	NN
work_myfomrpabnam7f4o57fxudm5bi	12	32	diovascular	diovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	33	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	12	34	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	12	35	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	12	36	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	12	37	conditions	condition	NNS
work_myfomrpabnam7f4o57fxudm5bi	12	38	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	12	39	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	12	40	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	12	41	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	12	42	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	12	43	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	12	44	ischemic	ischemic	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	45	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	12	46	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	12	47	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	12	48	cerebrovascular	cerebrovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	12	49	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	12	50	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	12	51	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	12	52	noncirculatory	noncirculatory	NN
work_myfomrpabnam7f4o57fxudm5bi	12	53	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	12	54	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	13	1	This	this	DT
work_myfomrpabnam7f4o57fxudm5bi	13	2	information	information	NN
work_myfomrpabnam7f4o57fxudm5bi	13	3	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	13	4	derived	derive	VBN
work_myfomrpabnam7f4o57fxudm5bi	13	5	mainly	mainly	RB
work_myfomrpabnam7f4o57fxudm5bi	13	6	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	13	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	13	8	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	9	Institute	Institute	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	10	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	13	11	Health	Health	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	12	In-	In-	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	13	formation	formation	NN
work_myfomrpabnam7f4o57fxudm5bi	13	14	Hospital	Hospital	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	15	Discharge	Discharge	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	16	Abstract	Abstract	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	17	Database	Database	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	18	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	13	19	serial	serial	JJ
work_myfomrpabnam7f4o57fxudm5bi	13	20	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	21	Community	Community	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	22	Health	Health	NNP
work_myfomrpabnam7f4o57fxudm5bi	13	23	Surveys	Surveys	NNPS
work_myfomrpabnam7f4o57fxudm5bi	13	24	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	14	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	14	2	changes	change	NNS
work_myfomrpabnam7f4o57fxudm5bi	14	3	over	over	IN
work_myfomrpabnam7f4o57fxudm5bi	14	4	these	these	DT
work_myfomrpabnam7f4o57fxudm5bi	14	5	2	2	CD
work_myfomrpabnam7f4o57fxudm5bi	14	6	decades	decade	NNS
work_myfomrpabnam7f4o57fxudm5bi	14	7	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	14	8	breathtaking	breathtake	VBG
work_myfomrpabnam7f4o57fxudm5bi	14	9	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	15	1	Age-	age-	CD
work_myfomrpabnam7f4o57fxudm5bi	15	2	standardized	standardized	JJ
work_myfomrpabnam7f4o57fxudm5bi	15	3	hospitalizations	hospitalization	NNS
work_myfomrpabnam7f4o57fxudm5bi	15	4	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	15	5	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	15	6	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	15	7	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	15	8	conditions	condition	NNS
work_myfomrpabnam7f4o57fxudm5bi	15	9	decreased	decrease	VBD
work_myfomrpabnam7f4o57fxudm5bi	15	10	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	15	11	54	54	CD
work_myfomrpabnam7f4o57fxudm5bi	15	12	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	15	13	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	15	14	both	both	DT
work_myfomrpabnam7f4o57fxudm5bi	15	15	men	man	NNS
work_myfomrpabnam7f4o57fxudm5bi	15	16	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	15	17	women	woman	NNS
work_myfomrpabnam7f4o57fxudm5bi	15	18	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	16	1	Ischemic	ischemic	JJ
work_myfomrpabnam7f4o57fxudm5bi	16	2	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	16	3	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	16	4	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	16	5	cerebrovascular	cerebrovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	16	6	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	16	7	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	16	8	decreased	decrease	VBD
work_myfomrpabnam7f4o57fxudm5bi	16	9	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	16	10	53	53	CD
work_myfomrpabnam7f4o57fxudm5bi	16	11	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	16	12	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	16	13	both	both	DT
work_myfomrpabnam7f4o57fxudm5bi	16	14	sexes	sex	NNS
work_myfomrpabnam7f4o57fxudm5bi	16	15	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	16	16	whereas	whereas	IN
work_myfomrpabnam7f4o57fxudm5bi	16	17	noncardiovascular	noncardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	16	18	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	16	19	declined	decline	VBD
work_myfomrpabnam7f4o57fxudm5bi	16	20	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	16	21	“	"	``
work_myfomrpabnam7f4o57fxudm5bi	16	22	only	only	RB
work_myfomrpabnam7f4o57fxudm5bi	16	23	”	"	''
work_myfomrpabnam7f4o57fxudm5bi	16	24	22	22	CD
work_myfomrpabnam7f4o57fxudm5bi	16	25	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	16	26	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	17	1	During	during	IN
work_myfomrpabnam7f4o57fxudm5bi	17	2	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	17	3	period	period	NN
work_myfomrpabnam7f4o57fxudm5bi	17	4	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	17	5	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	17	6	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	17	7	standardized	standardized	JJ
work_myfomrpabnam7f4o57fxudm5bi	17	8	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	17	9	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	17	10	percutaneous	percutaneous	JJ
work_myfomrpabnam7f4o57fxudm5bi	17	11	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	17	12	intervention	intervention	NN
work_myfomrpabnam7f4o57fxudm5bi	17	13	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	17	14	PCI	PCI	NNP
work_myfomrpabnam7f4o57fxudm5bi	17	15	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	17	16	increased	increase	VBD
work_myfomrpabnam7f4o57fxudm5bi	17	17	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	17	18	approximately	approximately	RB
work_myfomrpabnam7f4o57fxudm5bi	17	19	100	100	CD
work_myfomrpabnam7f4o57fxudm5bi	17	20	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	17	21	>	>	XX
work_myfomrpabnam7f4o57fxudm5bi	17	22	300	300	CD
work_myfomrpabnam7f4o57fxudm5bi	17	23	per	per	IN
work_myfomrpabnam7f4o57fxudm5bi	17	24	100,000	100,000	CD
work_myfomrpabnam7f4o57fxudm5bi	17	25	population	population	NN
work_myfomrpabnam7f4o57fxudm5bi	17	26	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	17	27	men	man	NNS
work_myfomrpabnam7f4o57fxudm5bi	17	28	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	17	29	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	17	30	approximately	approximately	RB
work_myfomrpabnam7f4o57fxudm5bi	17	31	40	40	CD
work_myfomrpabnam7f4o57fxudm5bi	17	32	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	17	33	110	110	CD
work_myfomrpabnam7f4o57fxudm5bi	17	34	per	per	IN
work_myfomrpabnam7f4o57fxudm5bi	17	35	100,000	100,000	CD
work_myfomrpabnam7f4o57fxudm5bi	17	36	popu-	popu-	JJ
work_myfomrpabnam7f4o57fxudm5bi	17	37	lation	lation	NN
work_myfomrpabnam7f4o57fxudm5bi	17	38	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	17	39	women	woman	NNS
work_myfomrpabnam7f4o57fxudm5bi	17	40	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	17	41	whereas	whereas	IN
work_myfomrpabnam7f4o57fxudm5bi	17	42	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	17	43	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	17	44	or	or	CC
work_myfomrpabnam7f4o57fxudm5bi	17	45	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	17	46	bypass	bypass	NN
work_myfomrpabnam7f4o57fxudm5bi	17	47	surgery	surgery	NN
work_myfomrpabnam7f4o57fxudm5bi	17	48	fell	fall	VBD
work_myfomrpabnam7f4o57fxudm5bi	17	49	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	17	50	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	17	51	lesser	less	JJR
work_myfomrpabnam7f4o57fxudm5bi	17	52	extent	extent	NN
work_myfomrpabnam7f4o57fxudm5bi	17	53	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	18	1	How	how	WRB
work_myfomrpabnam7f4o57fxudm5bi	18	2	Do	do	VBP
work_myfomrpabnam7f4o57fxudm5bi	18	3	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	18	4	Explain	explain	VB
work_myfomrpabnam7f4o57fxudm5bi	18	5	These	these	DT
work_myfomrpabnam7f4o57fxudm5bi	18	6	Improvements	improvement	NNS
work_myfomrpabnam7f4o57fxudm5bi	18	7	?	?	.
work_myfomrpabnam7f4o57fxudm5bi	19	1	Tu	Tu	NNP
work_myfomrpabnam7f4o57fxudm5bi	19	2	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	19	3	al.5	al.5	VBP
work_myfomrpabnam7f4o57fxudm5bi	19	4	attribute	attribute	VB
work_myfomrpabnam7f4o57fxudm5bi	19	5	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	19	6	fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	19	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	19	8	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	19	9	hospitalizations	hospitalization	NNS
work_myfomrpabnam7f4o57fxudm5bi	19	10	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	19	11	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	19	12	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	19	13	better	well	JJR
work_myfomrpabnam7f4o57fxudm5bi	19	14	control	control	NN
work_myfomrpabnam7f4o57fxudm5bi	19	15	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	19	16	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	19	17	factorsdspecifically	factorsdspecifically	RB
work_myfomrpabnam7f4o57fxudm5bi	19	18	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	19	19	smoking	smoking	NN
work_myfomrpabnam7f4o57fxudm5bi	19	20	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	19	21	hypertension	hypertension	NN
work_myfomrpabnam7f4o57fxudm5bi	19	22	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	19	23	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	19	24	greater	great	JJR
work_myfomrpabnam7f4o57fxudm5bi	19	25	use	use	NN
work_myfomrpabnam7f4o57fxudm5bi	19	26	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	19	27	cholesterol-	cholesterol-	NN
work_myfomrpabnam7f4o57fxudm5bi	19	28	lowering	lower	VBG
work_myfomrpabnam7f4o57fxudm5bi	19	29	therapydalong	therapydalong	JJ
work_myfomrpabnam7f4o57fxudm5bi	19	30	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	19	31	increasing	increase	VBG
work_myfomrpabnam7f4o57fxudm5bi	19	32	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	19	33	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	19	34	PCI	PCI	NNP
work_myfomrpabnam7f4o57fxudm5bi	19	35	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	20	1	As	as	IN
work_myfomrpabnam7f4o57fxudm5bi	20	2	they	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	20	3	point	point	VBP
work_myfomrpabnam7f4o57fxudm5bi	20	4	out	out	RP
work_myfomrpabnam7f4o57fxudm5bi	20	5	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	20	6	similar	similar	JJ
work_myfomrpabnam7f4o57fxudm5bi	20	7	improvements	improvement	NNS
work_myfomrpabnam7f4o57fxudm5bi	20	8	have	have	VBP
work_myfomrpabnam7f4o57fxudm5bi	20	9	been	be	VBN
work_myfomrpabnam7f4o57fxudm5bi	20	10	described	describe	VBN
work_myfomrpabnam7f4o57fxudm5bi	20	11	over	over	IN
work_myfomrpabnam7f4o57fxudm5bi	20	12	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	20	13	period	period	NN
work_myfomrpabnam7f4o57fxudm5bi	20	14	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	20	15	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	20	16	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	20	17	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	20	18	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	20	19	Western	Western	NNP
work_myfomrpabnam7f4o57fxudm5bi	20	20	Europe	Europe	NNP
work_myfomrpabnam7f4o57fxudm5bi	20	21	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	20	22	although	although	IN
work_myfomrpabnam7f4o57fxudm5bi	20	23	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	20	24	simultaneously	simultaneously	RB
work_myfomrpabnam7f4o57fxudm5bi	20	25	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	20	26	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	20	27	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	20	28	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	20	29	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	20	30	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	20	31	condi-	condi-	NN
work_myfomrpabnam7f4o57fxudm5bi	20	32	tions	tion	NNS
work_myfomrpabnam7f4o57fxudm5bi	20	33	tracked	track	VBN
work_myfomrpabnam7f4o57fxudm5bi	20	34	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	20	35	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	20	36	study	study	NN
work_myfomrpabnam7f4o57fxudm5bi	20	37	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	21	1	Several	several	JJ
work_myfomrpabnam7f4o57fxudm5bi	21	2	investigators	investigator	NNS
work_myfomrpabnam7f4o57fxudm5bi	21	3	have	have	VBP
work_myfomrpabnam7f4o57fxudm5bi	21	4	provided	provide	VBN
work_myfomrpabnam7f4o57fxudm5bi	21	5	precise	precise	JJ
work_myfomrpabnam7f4o57fxudm5bi	21	6	estimates	estimate	NNS
work_myfomrpabnam7f4o57fxudm5bi	21	7	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	21	8	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	21	9	contributions	contribution	NNS
work_myfomrpabnam7f4o57fxudm5bi	21	10	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	21	11	different	different	JJ
work_myfomrpabnam7f4o57fxudm5bi	21	12	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	21	13	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	21	14	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	21	15	fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	21	16	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	21	17	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	21	18	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	21	19	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	22	1	For	for	IN
work_myfomrpabnam7f4o57fxudm5bi	22	2	example	example	NN
work_myfomrpabnam7f4o57fxudm5bi	22	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	22	4	1	1	CD
work_myfomrpabnam7f4o57fxudm5bi	22	5	group	group	NN
work_myfomrpabnam7f4o57fxudm5bi	22	6	stated	state	VBD
work_myfomrpabnam7f4o57fxudm5bi	22	7	that	that	IN
work_myfomrpabnam7f4o57fxudm5bi	22	8	25	25	CD
work_myfomrpabnam7f4o57fxudm5bi	22	9	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	22	10	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	22	11	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	22	12	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	22	13	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	22	14	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	15	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	22	16	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	22	17	1980	1980	CD
work_myfomrpabnam7f4o57fxudm5bi	22	18	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	22	19	1990	1990	CD
work_myfomrpabnam7f4o57fxudm5bi	22	20	could	could	MD
work_myfomrpabnam7f4o57fxudm5bi	22	21	be	be	VB
work_myfomrpabnam7f4o57fxudm5bi	22	22	attributed	attribute	VBN
work_myfomrpabnam7f4o57fxudm5bi	22	23	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	22	24	primary	primary	JJ
work_myfomrpabnam7f4o57fxudm5bi	22	25	prevention	prevention	NN
work_myfomrpabnam7f4o57fxudm5bi	22	26	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	22	27	whereas	whereas	IN
work_myfomrpabnam7f4o57fxudm5bi	22	28	29	29	CD
work_myfomrpabnam7f4o57fxudm5bi	22	29	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	22	30	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	22	31	explained	explain	VBN
work_myfomrpabnam7f4o57fxudm5bi	22	32	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	22	33	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	22	34	secondary	secondary	JJ
work_myfomrpabnam7f4o57fxudm5bi	22	35	reduction	reduction	NN
work_myfomrpabnam7f4o57fxudm5bi	22	36	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	22	37	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	22	38	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	22	39	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	22	40	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	22	41	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	22	42	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	43	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	22	44	43	43	CD
work_myfomrpabnam7f4o57fxudm5bi	22	45	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	22	46	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	22	47	other	other	JJ
work_myfomrpabnam7f4o57fxudm5bi	22	48	improvements	improvement	NNS
work_myfomrpabnam7f4o57fxudm5bi	22	49	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	22	50	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	22	51	treatment	treatment	NN
work_myfomrpabnam7f4o57fxudm5bi	22	52	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	22	53	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	22	54	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	22	55	CHD.6	CHD.6	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	56	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	22	57	serial	serial	JJ
work_myfomrpabnam7f4o57fxudm5bi	22	58	population	population	NN
work_myfomrpabnam7f4o57fxudm5bi	22	59	surveys	survey	NNS
work_myfomrpabnam7f4o57fxudm5bi	22	60	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	22	61	Norway	Norway	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	62	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	22	63	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	22	64	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	22	65	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	22	66	CHD	CHD	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	67	decreased	decrease	VBD
work_myfomrpabnam7f4o57fxudm5bi	22	68	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	22	69	3	3	CD
work_myfomrpabnam7f4o57fxudm5bi	22	70	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	22	71	per	per	IN
work_myfomrpabnam7f4o57fxudm5bi	22	72	year	year	NN
work_myfomrpabnam7f4o57fxudm5bi	22	73	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	22	74	1994	1994	CD
work_myfomrpabnam7f4o57fxudm5bi	22	75	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	22	76	2008.7	2008.7	CD
work_myfomrpabnam7f4o57fxudm5bi	22	77	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	78	Journal	Journal	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	79	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	22	80	Cardiology	Cardiology	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	81	33	33	CD
work_myfomrpabnam7f4o57fxudm5bi	22	82	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	22	83	2017	2017	CD
work_myfomrpabnam7f4o57fxudm5bi	22	84	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	22	85	295e297	295e297	CD
work_myfomrpabnam7f4o57fxudm5bi	22	86	Received	receive	VBN
work_myfomrpabnam7f4o57fxudm5bi	22	87	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	22	88	publication	publication	NN
work_myfomrpabnam7f4o57fxudm5bi	22	89	November	November	NNP
work_myfomrpabnam7f4o57fxudm5bi	22	90	15	15	CD
work_myfomrpabnam7f4o57fxudm5bi	22	91	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	22	92	2016	2016	CD
work_myfomrpabnam7f4o57fxudm5bi	22	93	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	23	1	Accepted	Accepted	NNP
work_myfomrpabnam7f4o57fxudm5bi	23	2	November	November	NNP
work_myfomrpabnam7f4o57fxudm5bi	23	3	17	17	CD
work_myfomrpabnam7f4o57fxudm5bi	23	4	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	23	5	2016	2016	CD
work_myfomrpabnam7f4o57fxudm5bi	23	6	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	24	1	Corresponding	correspond	VBG
work_myfomrpabnam7f4o57fxudm5bi	24	2	author	author	NN
work_myfomrpabnam7f4o57fxudm5bi	24	3	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	24	4	David	David	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	5	D.	D.	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	6	Waters	Waters	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	7	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	8	MD	MD	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	10	Division	Division	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	11	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	24	12	Cardiology	Cardiology	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	13	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	14	Rm	Rm	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	15	5G1	5G1	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	16	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	17	San	San	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	18	Francisco	Francisco	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	19	General	General	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	20	Hospital	Hospital	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	21	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	22	1001	1001	CD
work_myfomrpabnam7f4o57fxudm5bi	24	23	Potrero	Potrero	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	24	Ave	Ave	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	25	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	26	San	San	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	27	Francisco	Francisco	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	28	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	29	California	California	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	30	94114	94114	CD
work_myfomrpabnam7f4o57fxudm5bi	24	31	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	24	32	USA	USA	NNP
work_myfomrpabnam7f4o57fxudm5bi	24	33	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	25	1	Tel	tel	NN
work_myfomrpabnam7f4o57fxudm5bi	25	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	26	1	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	26	2	þ1	þ1	NNP
work_myfomrpabnam7f4o57fxudm5bi	26	3	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	26	4	415	415	CD
work_myfomrpabnam7f4o57fxudm5bi	26	5	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	26	6	420	420	CD
work_myfomrpabnam7f4o57fxudm5bi	26	7	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	26	8	6646	6646	CD
work_myfomrpabnam7f4o57fxudm5bi	26	9	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	27	1	E	e	NN
work_myfomrpabnam7f4o57fxudm5bi	27	2	-	-	NN
work_myfomrpabnam7f4o57fxudm5bi	27	3	mail	mail	NN
work_myfomrpabnam7f4o57fxudm5bi	27	4	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	27	5	david.waters@ucsf.edu	david.waters@ucsf.edu	ADD
work_myfomrpabnam7f4o57fxudm5bi	27	6	See	see	VB
work_myfomrpabnam7f4o57fxudm5bi	27	7	page	page	NN
work_myfomrpabnam7f4o57fxudm5bi	27	8	296	296	CD
work_myfomrpabnam7f4o57fxudm5bi	27	9	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	27	10	disclosure	disclosure	NN
work_myfomrpabnam7f4o57fxudm5bi	27	11	information	information	NN
work_myfomrpabnam7f4o57fxudm5bi	27	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	28	1	http://dx.doi.org/10.1016/j.cjca.2016.11.012	http://dx.doi.org/10.1016/j.cjca.2016.11.012	NNP
work_myfomrpabnam7f4o57fxudm5bi	28	2	0828	0828	CD
work_myfomrpabnam7f4o57fxudm5bi	28	3	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	28	4	282X/	282x/	CD
work_myfomrpabnam7f4o57fxudm5bi	28	5	!	!	.
work_myfomrpabnam7f4o57fxudm5bi	29	1	2016	2016	CD
work_myfomrpabnam7f4o57fxudm5bi	29	2	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	29	3	Cardiovascular	Cardiovascular	NNP
work_myfomrpabnam7f4o57fxudm5bi	29	4	Society	Society	NNP
work_myfomrpabnam7f4o57fxudm5bi	29	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	30	1	Published	publish	VBN
work_myfomrpabnam7f4o57fxudm5bi	30	2	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	30	3	Elsevier	Elsevier	NNP
work_myfomrpabnam7f4o57fxudm5bi	30	4	Inc.	Inc.	NNP
work_myfomrpabnam7f4o57fxudm5bi	30	5	All	all	DT
work_myfomrpabnam7f4o57fxudm5bi	30	6	rights	right	NNS
work_myfomrpabnam7f4o57fxudm5bi	30	7	reserved	reserve	VBN
work_myfomrpabnam7f4o57fxudm5bi	30	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	31	1	http://dx.doi.org/10.1016/j.cjca.2016.11.012	http://dx.doi.org/10.1016/j.cjca.2016.11.012	PRP
work_myfomrpabnam7f4o57fxudm5bi	31	2	http://dx.doi.org/10.1016/j.cjca.2016.11.012	http://dx.doi.org/10.1016/j.cjca.2016.11.012	NNP
work_myfomrpabnam7f4o57fxudm5bi	31	3	mailto:david.waters@ucsf.edu	mailto:david.waters@ucsf.edu	NNP
work_myfomrpabnam7f4o57fxudm5bi	31	4	http://crossmark.crossref.org/dialog/?doi=10.1016/j.cjca.2016.11.012&domain=pdf	http://crossmark.crossref.org/dialog/?doi=10.1016/j.cjca.2016.11.012&domain=pdf	NNP
work_myfomrpabnam7f4o57fxudm5bi	31	5	http://dx.doi.org/10.1016/j.cjca.2016.11.012	http://dx.doi.org/10.1016/j.cjca.2016.11.012	NNP
work_myfomrpabnam7f4o57fxudm5bi	31	6	Changes	change	NNS
work_myfomrpabnam7f4o57fxudm5bi	31	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	31	8	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	31	9	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	31	10	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	31	11	accounted	account	VBD
work_myfomrpabnam7f4o57fxudm5bi	31	12	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	31	13	66	66	CD
work_myfomrpabnam7f4o57fxudm5bi	31	14	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	31	15	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	31	16	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	31	17	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	31	18	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	19	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	31	20	improvements	improvement	NNS
work_myfomrpabnam7f4o57fxudm5bi	31	21	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	31	22	cholesterol	cholesterol	NN
work_myfomrpabnam7f4o57fxudm5bi	31	23	levels	level	NNS
work_myfomrpabnam7f4o57fxudm5bi	31	24	contributing	contribute	VBG
work_myfomrpabnam7f4o57fxudm5bi	31	25	32	32	CD
work_myfomrpabnam7f4o57fxudm5bi	31	26	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	31	27	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	28	whereas	whereas	IN
work_myfomrpabnam7f4o57fxudm5bi	31	29	reduced	reduced	JJ
work_myfomrpabnam7f4o57fxudm5bi	31	30	blood	blood	NN
work_myfomrpabnam7f4o57fxudm5bi	31	31	pressure	pressure	NN
work_myfomrpabnam7f4o57fxudm5bi	31	32	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	33	giving	give	VBG
work_myfomrpabnam7f4o57fxudm5bi	31	34	up	up	RP
work_myfomrpabnam7f4o57fxudm5bi	31	35	smoking	smoking	NN
work_myfomrpabnam7f4o57fxudm5bi	31	36	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	37	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	31	38	physical	physical	JJ
work_myfomrpabnam7f4o57fxudm5bi	31	39	activity	activity	NN
work_myfomrpabnam7f4o57fxudm5bi	31	40	contributed	contribute	VBD
work_myfomrpabnam7f4o57fxudm5bi	31	41	14	14	CD
work_myfomrpabnam7f4o57fxudm5bi	31	42	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	31	43	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	44	13	13	CD
work_myfomrpabnam7f4o57fxudm5bi	31	45	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	31	46	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	47	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	31	48	9	9	CD
work_myfomrpabnam7f4o57fxudm5bi	31	49	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	31	50	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	31	51	respectively	respectively	RB
work_myfomrpabnam7f4o57fxudm5bi	31	52	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	32	1	Although	although	IN
work_myfomrpabnam7f4o57fxudm5bi	32	2	studies	study	NNS
work_myfomrpabnam7f4o57fxudm5bi	32	3	such	such	JJ
work_myfomrpabnam7f4o57fxudm5bi	32	4	as	as	IN
work_myfomrpabnam7f4o57fxudm5bi	32	5	these	these	DT
work_myfomrpabnam7f4o57fxudm5bi	32	6	appear	appear	VBP
work_myfomrpabnam7f4o57fxudm5bi	32	7	highly	highly	RB
work_myfomrpabnam7f4o57fxudm5bi	32	8	credible	credible	JJ
work_myfomrpabnam7f4o57fxudm5bi	32	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	32	10	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	32	11	part	part	NN
work_myfomrpabnam7f4o57fxudm5bi	32	12	because	because	IN
work_myfomrpabnam7f4o57fxudm5bi	32	13	they	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	32	14	provide	provide	VBP
work_myfomrpabnam7f4o57fxudm5bi	32	15	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	32	16	high	high	JJ
work_myfomrpabnam7f4o57fxudm5bi	32	17	degree	degree	NN
work_myfomrpabnam7f4o57fxudm5bi	32	18	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	32	19	precision	precision	NN
work_myfomrpabnam7f4o57fxudm5bi	32	20	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	32	21	they	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	32	22	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	32	23	fact	fact	NN
work_myfomrpabnam7f4o57fxudm5bi	32	24	describe	describe	VB
work_myfomrpabnam7f4o57fxudm5bi	32	25	associations	association	NNS
work_myfomrpabnam7f4o57fxudm5bi	32	26	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	32	27	do	do	VBP
work_myfomrpabnam7f4o57fxudm5bi	32	28	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	32	29	prove	prove	VB
work_myfomrpabnam7f4o57fxudm5bi	32	30	causality	causality	NN
work_myfomrpabnam7f4o57fxudm5bi	32	31	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	33	1	Never-	Never-	NNP
work_myfomrpabnam7f4o57fxudm5bi	33	2	theless	theless	NN
work_myfomrpabnam7f4o57fxudm5bi	33	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	33	4	plans	plan	VBZ
work_myfomrpabnam7f4o57fxudm5bi	33	5	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	33	6	reduce	reduce	VB
work_myfomrpabnam7f4o57fxudm5bi	33	7	ACSVD	ACSVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	33	8	usually	usually	RB
work_myfomrpabnam7f4o57fxudm5bi	33	9	revolve	revolve	VB
work_myfomrpabnam7f4o57fxudm5bi	33	10	around	around	IN
work_myfomrpabnam7f4o57fxudm5bi	33	11	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	33	12	factor	factor	NN
work_myfomrpabnam7f4o57fxudm5bi	33	13	reduction	reduction	NN
work_myfomrpabnam7f4o57fxudm5bi	33	14	strategies	strategy	NNS
work_myfomrpabnam7f4o57fxudm5bi	33	15	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	34	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	34	2	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	34	3	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	4	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	5	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	6	eg	eg	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	7	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	8	Healthy	Healthy	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	9	People	People	NNS
work_myfomrpabnam7f4o57fxudm5bi	34	10	2020	2020	CD
work_myfomrpabnam7f4o57fxudm5bi	34	11	aims	aim	VBZ
work_myfomrpabnam7f4o57fxudm5bi	34	12	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	34	13	reduce	reduce	VB
work_myfomrpabnam7f4o57fxudm5bi	34	14	fatal	fatal	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	15	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	16	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	34	17	20	20	CD
work_myfomrpabnam7f4o57fxudm5bi	34	18	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	34	19	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	34	20	2020	2020	CD
work_myfomrpabnam7f4o57fxudm5bi	34	21	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	22	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	34	23	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	34	24	strategy	strategy	NN
work_myfomrpabnam7f4o57fxudm5bi	34	25	based	base	VBN
work_myfomrpabnam7f4o57fxudm5bi	34	26	mainly	mainly	RB
work_myfomrpabnam7f4o57fxudm5bi	34	27	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	34	28	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	34	29	factor	factor	NN
work_myfomrpabnam7f4o57fxudm5bi	34	30	reduction.8	reduction.8	.
work_myfomrpabnam7f4o57fxudm5bi	34	31	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	34	32	New	New	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	33	Mountain	Mountain	NNP
work_myfomrpabnam7f4o57fxudm5bi	34	34	Although	although	IN
work_myfomrpabnam7f4o57fxudm5bi	34	35	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	34	36	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	34	37	conquered	conquer	VBN
work_myfomrpabnam7f4o57fxudm5bi	34	38	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	34	39	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	34	40	first	first	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	41	half	half	NN
work_myfomrpabnam7f4o57fxudm5bi	34	42	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	34	43	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	34	44	20th	20th	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	45	century	century	NN
work_myfomrpabnam7f4o57fxudm5bi	34	46	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	47	it	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	34	48	did	do	VBD
work_myfomrpabnam7f4o57fxudm5bi	34	49	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	34	50	vanish	vanish	VB
work_myfomrpabnam7f4o57fxudm5bi	34	51	but	but	CC
work_myfomrpabnam7f4o57fxudm5bi	34	52	only	only	RB
work_myfomrpabnam7f4o57fxudm5bi	34	53	retreated	retreat	VBD
work_myfomrpabnam7f4o57fxudm5bi	34	54	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	34	55	niches	niche	NNS
work_myfomrpabnam7f4o57fxudm5bi	34	56	where	where	WRB
work_myfomrpabnam7f4o57fxudm5bi	34	57	it	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	34	58	could	could	MD
work_myfomrpabnam7f4o57fxudm5bi	34	59	thrive	thrive	VB
work_myfomrpabnam7f4o57fxudm5bi	34	60	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	61	such	such	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	62	as	as	IN
work_myfomrpabnam7f4o57fxudm5bi	34	63	disadvantaged	disadvantaged	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	64	inner	inner	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	65	cities	city	NNS
work_myfomrpabnam7f4o57fxudm5bi	34	66	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	67	Canadian	canadian	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	68	aboriginal	aboriginal	JJ
work_myfomrpabnam7f4o57fxudm5bi	34	69	communities	community	NNS
work_myfomrpabnam7f4o57fxudm5bi	34	70	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	34	71	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	34	72	developing	develop	VBG
work_myfomrpabnam7f4o57fxudm5bi	34	73	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	34	74	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	35	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	35	2	spread	spread	NN
work_myfomrpabnam7f4o57fxudm5bi	35	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	35	4	HIV	HIV	NNP
work_myfomrpabnam7f4o57fxudm5bi	35	5	has	have	VBZ
work_myfomrpabnam7f4o57fxudm5bi	35	6	led	lead	VBN
work_myfomrpabnam7f4o57fxudm5bi	35	7	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	35	8	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	35	9	resurgence	resurgence	NN
work_myfomrpabnam7f4o57fxudm5bi	35	10	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	35	11	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	35	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	36	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	36	2	1997	1997	CD
work_myfomrpabnam7f4o57fxudm5bi	36	3	worldwide	worldwide	RB
work_myfomrpabnam7f4o57fxudm5bi	36	4	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	36	5	new	new	JJ
work_myfomrpabnam7f4o57fxudm5bi	36	6	cases	case	NNS
work_myfomrpabnam7f4o57fxudm5bi	36	7	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	36	8	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	36	9	totaled	total	VBD
work_myfomrpabnam7f4o57fxudm5bi	36	10	almost	almost	RB
work_myfomrpabnam7f4o57fxudm5bi	36	11	8	8	CD
work_myfomrpabnam7f4o57fxudm5bi	36	12	million	million	CD
work_myfomrpabnam7f4o57fxudm5bi	36	13	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	36	14	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	36	15	1.87	1.87	CD
work_myfomrpabnam7f4o57fxudm5bi	36	16	million	million	CD
work_myfomrpabnam7f4o57fxudm5bi	36	17	deaths	death	NNS
work_myfomrpabnam7f4o57fxudm5bi	36	18	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	36	19	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	36	20	global	global	JJ
work_myfomrpabnam7f4o57fxudm5bi	36	21	case	case	NN
work_myfomrpabnam7f4o57fxudm5bi	36	22	fatality	fatality	NN
work_myfomrpabnam7f4o57fxudm5bi	36	23	rate	rate	NN
work_myfomrpabnam7f4o57fxudm5bi	36	24	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	36	25	23%.9	23%.9	CD
work_myfomrpabnam7f4o57fxudm5bi	36	26	Latent	Latent	NNP
work_myfomrpabnam7f4o57fxudm5bi	36	27	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	36	28	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	36	29	present	present	JJ
work_myfomrpabnam7f4o57fxudm5bi	36	30	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	36	31	approximately	approximately	RB
work_myfomrpabnam7f4o57fxudm5bi	36	32	2	2	CD
work_myfomrpabnam7f4o57fxudm5bi	36	33	billion	billion	CD
work_myfomrpabnam7f4o57fxudm5bi	36	34	individuals	individual	NNS
work_myfomrpabnam7f4o57fxudm5bi	36	35	across	across	IN
work_myfomrpabnam7f4o57fxudm5bi	36	36	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	36	37	globe	globe	NN
work_myfomrpabnam7f4o57fxudm5bi	36	38	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	37	1	There	there	EX
work_myfomrpabnam7f4o57fxudm5bi	37	2	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	37	3	ominous	ominous	JJ
work_myfomrpabnam7f4o57fxudm5bi	37	4	signs	sign	NNS
work_myfomrpabnam7f4o57fxudm5bi	37	5	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	37	6	suggest	suggest	VB
work_myfomrpabnam7f4o57fxudm5bi	37	7	that	that	IN
work_myfomrpabnam7f4o57fxudm5bi	37	8	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	37	9	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	37	10	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	37	11	about	about	IN
work_myfomrpabnam7f4o57fxudm5bi	37	12	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	37	13	fade	fade	VB
work_myfomrpabnam7f4o57fxudm5bi	37	14	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	37	15	view	view	NN
work_myfomrpabnam7f4o57fxudm5bi	37	16	either	either	RB
work_myfomrpabnam7f4o57fxudm5bi	37	17	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	38	1	Tu	Tu	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	2	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	3	al.5	al.5	NN
work_myfomrpabnam7f4o57fxudm5bi	38	4	note	note	VB
work_myfomrpabnam7f4o57fxudm5bi	38	5	that	that	IN
work_myfomrpabnam7f4o57fxudm5bi	38	6	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	38	7	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	8	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	38	9	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	38	10	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	11	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	12	“	"	``
work_myfomrpabnam7f4o57fxudm5bi	38	13	were	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	38	14	least	least	RBS
work_myfomrpabnam7f4o57fxudm5bi	38	15	evident	evident	JJ
work_myfomrpabnam7f4o57fxudm5bi	38	16	among	among	IN
work_myfomrpabnam7f4o57fxudm5bi	38	17	those	those	DT
work_myfomrpabnam7f4o57fxudm5bi	38	18	aged	age	VBN
work_myfomrpabnam7f4o57fxudm5bi	38	19	20	20	CD
work_myfomrpabnam7f4o57fxudm5bi	38	20	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	38	21	49	49	CD
work_myfomrpabnam7f4o57fxudm5bi	38	22	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	38	23	both	both	DT
work_myfomrpabnam7f4o57fxudm5bi	38	24	sexes	sex	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	25	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	38	26	”	"	''
work_myfomrpabnam7f4o57fxudm5bi	38	27	Reports	report	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	28	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	38	29	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	38	30	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	31	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	32	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	38	33	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	38	34	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	35	Kingdom	Kingdom	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	36	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	38	37	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	38	38	Australia	Australia	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	39	also	also	RB
work_myfomrpabnam7f4o57fxudm5bi	38	40	indicate	indicate	VBP
work_myfomrpabnam7f4o57fxudm5bi	38	41	that	that	IN
work_myfomrpabnam7f4o57fxudm5bi	38	42	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	43	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	44	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	38	45	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	38	46	decreasing	decrease	VBG
work_myfomrpabnam7f4o57fxudm5bi	38	47	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	38	48	indeed	indeed	RB
work_myfomrpabnam7f4o57fxudm5bi	38	49	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	50	some	some	DT
work_myfomrpabnam7f4o57fxudm5bi	38	51	instances	instance	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	52	appear	appear	VBP
work_myfomrpabnam7f4o57fxudm5bi	38	53	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	38	54	be	be	VB
work_myfomrpabnam7f4o57fxudm5bi	38	55	increasing	increase	VBG
work_myfomrpabnam7f4o57fxudm5bi	38	56	slightly	slightly	RB
work_myfomrpabnam7f4o57fxudm5bi	38	57	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	58	younger	young	JJR
work_myfomrpabnam7f4o57fxudm5bi	38	59	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	38	60	strata	strata	NN
work_myfomrpabnam7f4o57fxudm5bi	38	61	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	38	62	particularly	particularly	RB
work_myfomrpabnam7f4o57fxudm5bi	38	63	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	64	women.10	women.10	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	65	-	-	:
work_myfomrpabnam7f4o57fxudm5bi	38	66	13	13	CD
work_myfomrpabnam7f4o57fxudm5bi	38	67	A	a	DT
work_myfomrpabnam7f4o57fxudm5bi	38	68	change	change	NN
work_myfomrpabnam7f4o57fxudm5bi	38	69	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	70	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	38	71	case	case	NN
work_myfomrpabnam7f4o57fxudm5bi	38	72	fatality	fatality	NN
work_myfomrpabnam7f4o57fxudm5bi	38	73	rate	rate	NN
work_myfomrpabnam7f4o57fxudm5bi	38	74	does	do	VBZ
work_myfomrpabnam7f4o57fxudm5bi	38	75	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	38	76	appear	appear	VB
work_myfomrpabnam7f4o57fxudm5bi	38	77	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	38	78	account	account	VB
work_myfomrpabnam7f4o57fxudm5bi	38	79	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	38	80	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	38	81	flattening	flattening	NN
work_myfomrpabnam7f4o57fxudm5bi	38	82	or	or	CC
work_myfomrpabnam7f4o57fxudm5bi	38	83	increased	increase	VBN
work_myfomrpabnam7f4o57fxudm5bi	38	84	CHD	chd	NN
work_myfomrpabnam7f4o57fxudm5bi	38	85	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	38	86	curve	curve	NN
work_myfomrpabnam7f4o57fxudm5bi	38	87	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	88	younger	young	JJR
work_myfomrpabnam7f4o57fxudm5bi	38	89	groups	group	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	90	;	;	:
work_myfomrpabnam7f4o57fxudm5bi	38	91	rather	rather	RB
work_myfomrpabnam7f4o57fxudm5bi	38	92	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	38	93	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	38	94	more	more	RBR
work_myfomrpabnam7f4o57fxudm5bi	38	95	likely	likely	JJ
work_myfomrpabnam7f4o57fxudm5bi	38	96	results	result	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	97	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	38	98	an	an	DT
work_myfomrpabnam7f4o57fxudm5bi	38	99	increase	increase	NN
work_myfomrpabnam7f4o57fxudm5bi	38	100	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	38	101	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	38	102	factors,13	factors,13	NNP
work_myfomrpabnam7f4o57fxudm5bi	38	103	specifically	specifically	RB
work_myfomrpabnam7f4o57fxudm5bi	38	104	surging	surge	VBG
work_myfomrpabnam7f4o57fxudm5bi	38	105	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	38	106	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	38	107	obesity	obesity	NN
work_myfomrpabnam7f4o57fxudm5bi	38	108	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	38	109	diabetes	diabetes	NN
work_myfomrpabnam7f4o57fxudm5bi	38	110	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	39	1	More	More	JJR
work_myfomrpabnam7f4o57fxudm5bi	39	2	than	than	IN
work_myfomrpabnam7f4o57fxudm5bi	39	3	80	80	CD
work_myfomrpabnam7f4o57fxudm5bi	39	4	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	39	5	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	6	deaths	death	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	7	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	39	8	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	9	now	now	RB
work_myfomrpabnam7f4o57fxudm5bi	39	10	occur	occur	VBP
work_myfomrpabnam7f4o57fxudm5bi	39	11	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	12	low-	low-	NN
work_myfomrpabnam7f4o57fxudm5bi	39	13	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	14	middle	middle	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	15	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	16	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	17	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	18	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	19	where	where	WRB
work_myfomrpabnam7f4o57fxudm5bi	39	20	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	21	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	39	22	continues	continue	VBZ
work_myfomrpabnam7f4o57fxudm5bi	39	23	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	39	24	rise.14,15	rise.14,15	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	25	Rates	Rates	NNPS
work_myfomrpabnam7f4o57fxudm5bi	39	26	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	27	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	28	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	29	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	30	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	39	31	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	39	32	higher	high	JJR
work_myfomrpabnam7f4o57fxudm5bi	39	33	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	34	low-	low-	NN
work_myfomrpabnam7f4o57fxudm5bi	39	35	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	36	middle	middle	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	37	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	38	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	39	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	40	compared	compare	VBN
work_myfomrpabnam7f4o57fxudm5bi	39	41	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	39	42	high	high	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	43	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	44	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	45	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	46	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	47	despite	despite	IN
work_myfomrpabnam7f4o57fxudm5bi	39	48	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	39	49	lower	low	JJR
work_myfomrpabnam7f4o57fxudm5bi	39	50	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	39	51	factor	factor	NN
work_myfomrpabnam7f4o57fxudm5bi	39	52	burden.15	burden.15	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	53	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	54	obvious	obvious	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	55	reason	reason	NN
work_myfomrpabnam7f4o57fxudm5bi	39	56	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	39	57	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	39	58	disparity	disparity	NN
work_myfomrpabnam7f4o57fxudm5bi	39	59	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	39	60	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	61	very	very	RB
work_myfomrpabnam7f4o57fxudm5bi	39	62	low	low	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	63	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	64	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	65	treatment	treatment	NN
work_myfomrpabnam7f4o57fxudm5bi	39	66	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	67	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	39	68	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	69	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	70	low-	low-	NN
work_myfomrpabnam7f4o57fxudm5bi	39	71	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	72	middle	middle	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	73	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	74	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	75	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	76	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	77	lower	low	JJR
work_myfomrpabnam7f4o57fxudm5bi	39	78	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	79	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	80	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	81	revascularization	revascularization	NN
work_myfomrpabnam7f4o57fxudm5bi	39	82	compared	compare	VBN
work_myfomrpabnam7f4o57fxudm5bi	39	83	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	39	84	high	high	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	85	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	86	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	87	countries.15	countries.15	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	88	Furthermore	furthermore	RB
work_myfomrpabnam7f4o57fxudm5bi	39	89	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	90	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	39	91	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	92	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	39	93	becoming	become	VBG
work_myfomrpabnam7f4o57fxudm5bi	39	94	more	more	RBR
work_myfomrpabnam7f4o57fxudm5bi	39	95	prevalent	prevalent	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	96	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	97	low-	low-	NN
work_myfomrpabnam7f4o57fxudm5bi	39	98	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	99	middle	middle	JJ
work_myfomrpabnam7f4o57fxudm5bi	39	100	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	39	101	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	39	102	coun-	coun-	NN
work_myfomrpabnam7f4o57fxudm5bi	39	103	tries	try	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	104	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	105	presaging	presage	VBG
work_myfomrpabnam7f4o57fxudm5bi	39	106	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	39	107	worsening	worsening	NN
work_myfomrpabnam7f4o57fxudm5bi	39	108	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	109	their	-PRON-	PRP$
work_myfomrpabnam7f4o57fxudm5bi	39	110	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	111	epidemics.16	epidemics.16	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	112	Social	Social	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	113	Deprivation	Deprivation	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	114	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	115	relationship	relationship	NN
work_myfomrpabnam7f4o57fxudm5bi	39	116	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	39	117	childhood	childhood	NN
work_myfomrpabnam7f4o57fxudm5bi	39	118	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	39	119	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	120	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	39	121	expectancy	expectancy	NN
work_myfomrpabnam7f4o57fxudm5bi	39	122	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	39	123	most	most	RBS
work_myfomrpabnam7f4o57fxudm5bi	39	124	colorfully	colorfully	RB
work_myfomrpabnam7f4o57fxudm5bi	39	125	depicted	depict	VBN
work_myfomrpabnam7f4o57fxudm5bi	39	126	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	127	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	39	128	map	map	NN
work_myfomrpabnam7f4o57fxudm5bi	39	129	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	39	130	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	131	London	London	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	132	Underground	Underground	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	133	created	create	VBN
work_myfomrpabnam7f4o57fxudm5bi	39	134	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	39	135	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	136	geographer	geographer	NN
work_myfomrpabnam7f4o57fxudm5bi	39	137	James	James	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	138	Cheshire	Cheshire	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	139	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	39	140	2012	2012	CD
work_myfomrpabnam7f4o57fxudm5bi	39	141	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	142	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	39	143	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	39	144	expectancy	expectancy	NN
work_myfomrpabnam7f4o57fxudm5bi	39	145	shown	show	VBN
work_myfomrpabnam7f4o57fxudm5bi	39	146	at	at	IN
work_myfomrpabnam7f4o57fxudm5bi	39	147	each	each	DT
work_myfomrpabnam7f4o57fxudm5bi	39	148	Underground	Underground	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	149	stop.17	stop.17	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	150	Going	Going	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	151	east	east	RB
work_myfomrpabnam7f4o57fxudm5bi	39	152	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	39	153	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	154	Central	Central	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	155	Line	Line	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	156	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	39	157	8	8	CD
work_myfomrpabnam7f4o57fxudm5bi	39	158	stops	stop	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	159	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	160	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	39	161	Oxford	Oxford	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	162	Circus	Circus	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	163	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	164	Mile	Mile	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	165	End	End	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	166	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	167	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	39	168	expectancy	expectancy	NN
work_myfomrpabnam7f4o57fxudm5bi	39	169	decreases	decrease	VBZ
work_myfomrpabnam7f4o57fxudm5bi	39	170	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	39	171	18	18	CD
work_myfomrpabnam7f4o57fxudm5bi	39	172	years	year	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	173	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	39	174	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	175	crossing	cross	VBG
work_myfomrpabnam7f4o57fxudm5bi	39	176	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	177	Thames	Thames	NNPS
work_myfomrpabnam7f4o57fxudm5bi	39	178	between	between	IN
work_myfomrpabnam7f4o57fxudm5bi	39	179	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	39	180	Pimlico	Pimlico	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	181	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	39	182	Vauxhall	Vauxhall	NNP
work_myfomrpabnam7f4o57fxudm5bi	39	183	stations	station	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	184	sees	see	VBZ
work_myfomrpabnam7f4o57fxudm5bi	39	185	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	39	186	expectancy	expectancy	NN
work_myfomrpabnam7f4o57fxudm5bi	39	187	drop	drop	NN
work_myfomrpabnam7f4o57fxudm5bi	39	188	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	39	189	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	39	190	years	year	NNS
work_myfomrpabnam7f4o57fxudm5bi	39	191	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	40	1	Social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	40	2	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	40	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	40	4	both	both	CC
work_myfomrpabnam7f4o57fxudm5bi	40	5	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	40	6	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	40	7	country	country	NN
work_myfomrpabnam7f4o57fxudm5bi	40	8	level	level	NN
work_myfomrpabnam7f4o57fxudm5bi	40	9	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	40	10	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	40	11	disad-	disad-	JJ
work_myfomrpabnam7f4o57fxudm5bi	40	12	vantaged	vantaged	JJ
work_myfomrpabnam7f4o57fxudm5bi	40	13	groups	group	NNS
work_myfomrpabnam7f4o57fxudm5bi	40	14	within	within	IN
work_myfomrpabnam7f4o57fxudm5bi	40	15	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	40	16	country	country	NN
work_myfomrpabnam7f4o57fxudm5bi	40	17	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	40	18	has	have	VBZ
work_myfomrpabnam7f4o57fxudm5bi	40	19	long	long	RB
work_myfomrpabnam7f4o57fxudm5bi	40	20	been	be	VBN
work_myfomrpabnam7f4o57fxudm5bi	40	21	linked	link	VBN
work_myfomrpabnam7f4o57fxudm5bi	40	22	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	40	23	an	an	DT
work_myfomrpabnam7f4o57fxudm5bi	40	24	increased	increase	VBN
work_myfomrpabnam7f4o57fxudm5bi	40	25	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	40	26	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	40	27	ACSVD	ACSVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	40	28	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	41	1	However	however	RB
work_myfomrpabnam7f4o57fxudm5bi	41	2	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	41	3	higher	high	JJR
work_myfomrpabnam7f4o57fxudm5bi	41	4	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	41	5	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	41	6	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	41	7	limited	limit	VBN
work_myfomrpabnam7f4o57fxudm5bi	41	8	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	41	9	just	just	RB
work_myfomrpabnam7f4o57fxudm5bi	41	10	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	41	11	lowest	low	JJS
work_myfomrpabnam7f4o57fxudm5bi	41	12	stratum	stratum	NN
work_myfomrpabnam7f4o57fxudm5bi	41	13	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	41	14	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	41	15	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	42	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	42	2	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	42	3	influential	influential	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	4	Whitehall	Whitehall	NNP
work_myfomrpabnam7f4o57fxudm5bi	42	5	study	study	NN
work_myfomrpabnam7f4o57fxudm5bi	42	6	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	42	7	17,530	17,530	CD
work_myfomrpabnam7f4o57fxudm5bi	42	8	British	british	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	9	civil	civil	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	10	servants	servant	NNS
work_myfomrpabnam7f4o57fxudm5bi	42	11	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	12	all	all	DT
work_myfomrpabnam7f4o57fxudm5bi	42	13	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	42	14	whom	whom	WP
work_myfomrpabnam7f4o57fxudm5bi	42	15	were	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	42	16	employed	employ	VBN
work_myfomrpabnam7f4o57fxudm5bi	42	17	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	42	18	none	none	NN
work_myfomrpabnam7f4o57fxudm5bi	42	19	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	42	20	whom	whom	WP
work_myfomrpabnam7f4o57fxudm5bi	42	21	were	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	42	22	considered	consider	VBN
work_myfomrpabnam7f4o57fxudm5bi	42	23	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	42	24	be	be	VB
work_myfomrpabnam7f4o57fxudm5bi	42	25	socially	socially	RB
work_myfomrpabnam7f4o57fxudm5bi	42	26	deprived	deprive	VBN
work_myfomrpabnam7f4o57fxudm5bi	42	27	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	28	10-year	10-year	CD
work_myfomrpabnam7f4o57fxudm5bi	42	29	CHD	chd	NN
work_myfomrpabnam7f4o57fxudm5bi	42	30	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	42	31	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	42	32	2.2	2.2	CD
work_myfomrpabnam7f4o57fxudm5bi	42	33	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	42	34	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	35	3.6	3.6	CD
work_myfomrpabnam7f4o57fxudm5bi	42	36	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	42	37	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	38	4.9	4.9	CD
work_myfomrpabnam7f4o57fxudm5bi	42	39	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	42	40	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	41	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	42	42	6.7	6.7	CD
work_myfomrpabnam7f4o57fxudm5bi	42	43	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	42	44	across	across	IN
work_myfomrpabnam7f4o57fxudm5bi	42	45	job	job	NN
work_myfomrpabnam7f4o57fxudm5bi	42	46	grade	grade	NN
work_myfomrpabnam7f4o57fxudm5bi	42	47	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	42	48	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	42	49	highest	high	JJS
work_myfomrpabnam7f4o57fxudm5bi	42	50	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	42	51	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	42	52	lowest	low	JJS
work_myfomrpabnam7f4o57fxudm5bi	42	53	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	42	54	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	42	55	difference	difference	NN
work_myfomrpabnam7f4o57fxudm5bi	42	56	that	that	WDT
work_myfomrpabnam7f4o57fxudm5bi	42	57	remained	remain	VBD
work_myfomrpabnam7f4o57fxudm5bi	42	58	statistically	statistically	RB
work_myfomrpabnam7f4o57fxudm5bi	42	59	significant	significant	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	60	even	even	RB
work_myfomrpabnam7f4o57fxudm5bi	42	61	after	after	IN
work_myfomrpabnam7f4o57fxudm5bi	42	62	controlling	control	VBG
work_myfomrpabnam7f4o57fxudm5bi	42	63	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	42	64	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	42	65	factors.18	factors.18	NNP
work_myfomrpabnam7f4o57fxudm5bi	42	66	Lack	Lack	NNP
work_myfomrpabnam7f4o57fxudm5bi	42	67	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	42	68	access	access	NN
work_myfomrpabnam7f4o57fxudm5bi	42	69	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	42	70	affordable	affordable	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	71	effective	effective	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	72	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	42	73	care	care	NN
work_myfomrpabnam7f4o57fxudm5bi	42	74	contributes	contribute	NNS
work_myfomrpabnam7f4o57fxudm5bi	42	75	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	42	76	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	42	77	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	42	78	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	43	1	Living	live	VBG
work_myfomrpabnam7f4o57fxudm5bi	43	2	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	43	3	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	43	4	disadvantaged	disadvantaged	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	5	neighborhood	neighborhood	NN
work_myfomrpabnam7f4o57fxudm5bi	43	6	compared	compare	VBN
work_myfomrpabnam7f4o57fxudm5bi	43	7	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	43	8	an	an	DT
work_myfomrpabnam7f4o57fxudm5bi	43	9	advantaged	advantage	VBN
work_myfomrpabnam7f4o57fxudm5bi	43	10	one	one	CD
work_myfomrpabnam7f4o57fxudm5bi	43	11	increases	increase	VBZ
work_myfomrpabnam7f4o57fxudm5bi	43	12	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	43	13	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	43	14	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	43	15	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	43	16	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	17	event	event	NN
work_myfomrpabnam7f4o57fxudm5bi	43	18	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	43	19	even	even	RB
work_myfomrpabnam7f4o57fxudm5bi	43	20	after	after	IN
work_myfomrpabnam7f4o57fxudm5bi	43	21	adjustment	adjustment	NN
work_myfomrpabnam7f4o57fxudm5bi	43	22	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	43	23	personal	personal	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	24	socioeco-	socioeco-	NN
work_myfomrpabnam7f4o57fxudm5bi	43	25	nomic	nomic	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	26	status.19	status.19	NNP
work_myfomrpabnam7f4o57fxudm5bi	43	27	Social	Social	NNP
work_myfomrpabnam7f4o57fxudm5bi	43	28	support	support	NN
work_myfomrpabnam7f4o57fxudm5bi	43	29	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	43	30	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	31	networks	network	NNS
work_myfomrpabnam7f4o57fxudm5bi	43	32	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	43	33	often	often	RB
work_myfomrpabnam7f4o57fxudm5bi	43	34	deficient	deficient	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	35	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	43	36	individuals	individual	NNS
work_myfomrpabnam7f4o57fxudm5bi	43	37	experiencing	experience	VBG
work_myfomrpabnam7f4o57fxudm5bi	43	38	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	43	39	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	43	40	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	44	1	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	2	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	44	3	study	study	NN
work_myfomrpabnam7f4o57fxudm5bi	44	4	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	44	5	32,624	32,624	CD
work_myfomrpabnam7f4o57fxudm5bi	44	6	male	male	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	7	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	44	8	care	care	NN
work_myfomrpabnam7f4o57fxudm5bi	44	9	professionals	professional	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	11	those	those	DT
work_myfomrpabnam7f4o57fxudm5bi	44	12	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	13	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	44	14	lowest	low	JJS
work_myfomrpabnam7f4o57fxudm5bi	44	15	stratum	stratum	NN
work_myfomrpabnam7f4o57fxudm5bi	44	16	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	44	17	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	18	support	support	NN
work_myfomrpabnam7f4o57fxudm5bi	44	19	had	have	VBD
work_myfomrpabnam7f4o57fxudm5bi	44	20	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	44	21	relative	relative	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	22	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	44	23	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	44	24	1.9	1.9	CD
work_myfomrpabnam7f4o57fxudm5bi	44	25	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	44	26	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	27	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	44	28	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	29	2.2	2.2	CD
work_myfomrpabnam7f4o57fxudm5bi	44	30	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	44	31	incident	incident	NN
work_myfomrpabnam7f4o57fxudm5bi	44	32	stroke	stroke	NN
work_myfomrpabnam7f4o57fxudm5bi	44	33	compared	compare	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	34	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	44	35	those	those	DT
work_myfomrpabnam7f4o57fxudm5bi	44	36	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	37	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	44	38	highest	high	JJS
work_myfomrpabnam7f4o57fxudm5bi	44	39	stratum.20	stratum.20	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	40	Social	Social	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	41	deprivation	deprivation	NN
work_myfomrpabnam7f4o57fxudm5bi	44	42	may	may	MD
work_myfomrpabnam7f4o57fxudm5bi	44	43	increase	increase	VB
work_myfomrpabnam7f4o57fxudm5bi	44	44	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	45	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	44	46	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	44	47	increasing	increase	VBG
work_myfomrpabnam7f4o57fxudm5bi	44	48	depression	depression	NN
work_myfomrpabnam7f4o57fxudm5bi	44	49	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	50	anxiety.21	anxiety.21	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	51	Depression	Depression	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	52	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	53	depres-	depres-	NN
work_myfomrpabnam7f4o57fxudm5bi	44	54	sive	sive	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	55	symptoms	symptom	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	56	have	have	VBP
work_myfomrpabnam7f4o57fxudm5bi	44	57	been	be	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	58	linked	link	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	59	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	44	60	increased	increase	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	61	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	62	morbidity	morbidity	NN
work_myfomrpabnam7f4o57fxudm5bi	44	63	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	64	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	44	65	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	66	many	many	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	67	studies	study	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	68	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	69	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	70	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	44	71	effect	effect	NN
work_myfomrpabnam7f4o57fxudm5bi	44	72	per-	per-	NN
work_myfomrpabnam7f4o57fxudm5bi	44	73	sists	sist	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	74	after	after	IN
work_myfomrpabnam7f4o57fxudm5bi	44	75	adjustment	adjustment	NN
work_myfomrpabnam7f4o57fxudm5bi	44	76	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	44	77	other	other	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	78	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	44	79	factors.21	factors.21	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	80	In	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	81	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	82	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	44	83	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	84	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	44	85	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	44	86	CVD	CVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	87	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	44	88	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	89	depression	depression	NN
work_myfomrpabnam7f4o57fxudm5bi	44	90	is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	44	91	associated	associate	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	92	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	44	93	higher	high	JJR
work_myfomrpabnam7f4o57fxudm5bi	44	94	levels	level	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	95	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	44	96	inflammatory	inflammatory	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	97	markers	marker	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	98	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	99	other	other	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	100	biomarkers	biomarker	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	101	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	44	102	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	44	103	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	104	greater	great	JJR
work_myfomrpabnam7f4o57fxudm5bi	44	105	platelet	platelet	NN
work_myfomrpabnam7f4o57fxudm5bi	44	106	reactivity	reactivity	NN
work_myfomrpabnam7f4o57fxudm5bi	44	107	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	108	reduced	reduce	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	109	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	44	110	rate	rate	NN
work_myfomrpabnam7f4o57fxudm5bi	44	111	variability	variability	NN
work_myfomrpabnam7f4o57fxudm5bi	44	112	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	44	113	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	114	impaired	impair	VBD
work_myfomrpabnam7f4o57fxudm5bi	44	115	vascular	vascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	116	function.21	function.21	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	117	Future	Future	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	118	Directions	Directions	NNPS
work_myfomrpabnam7f4o57fxudm5bi	44	119	Further	further	JJ
work_myfomrpabnam7f4o57fxudm5bi	44	120	reductions	reduction	NNS
work_myfomrpabnam7f4o57fxudm5bi	44	121	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	44	122	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	44	123	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	44	124	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	44	125	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	44	126	should	should	MD
work_myfomrpabnam7f4o57fxudm5bi	44	127	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	44	128	be	be	VB
work_myfomrpabnam7f4o57fxudm5bi	44	129	taken	take	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	130	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	44	131	granted	grant	VBN
work_myfomrpabnam7f4o57fxudm5bi	44	132	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	45	1	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	45	2	must	must	MD
work_myfomrpabnam7f4o57fxudm5bi	45	3	apply	apply	VB
work_myfomrpabnam7f4o57fxudm5bi	45	4	secondary	secondary	JJ
work_myfomrpabnam7f4o57fxudm5bi	45	5	prevention	prevention	NN
work_myfomrpabnam7f4o57fxudm5bi	45	6	more	more	RBR
work_myfomrpabnam7f4o57fxudm5bi	45	7	comprehensively	comprehensively	RB
work_myfomrpabnam7f4o57fxudm5bi	45	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	46	1	Among	among	IN
work_myfomrpabnam7f4o57fxudm5bi	46	2	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	46	3	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	46	4	established	establish	VBN
work_myfomrpabnam7f4o57fxudm5bi	46	5	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	46	6	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	46	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	46	8	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	46	9	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	46	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	46	11	statin	statin	NN
work_myfomrpabnam7f4o57fxudm5bi	46	12	drug	drug	NN
work_myfomrpabnam7f4o57fxudm5bi	46	13	use	use	NN
work_myfomrpabnam7f4o57fxudm5bi	46	14	was	be	VBD
work_myfomrpabnam7f4o57fxudm5bi	46	15	at	at	IN
work_myfomrpabnam7f4o57fxudm5bi	46	16	49.8	49.8	CD
work_myfomrpabnam7f4o57fxudm5bi	46	17	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	46	18	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	46	19	2002	2002	CD
work_myfomrpabnam7f4o57fxudm5bi	46	20	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	46	21	2003	2003	CD
work_myfomrpabnam7f4o57fxudm5bi	46	22	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	46	23	despite	despite	IN
work_myfomrpabnam7f4o57fxudm5bi	46	24	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	46	25	decrease	decrease	NN
work_myfomrpabnam7f4o57fxudm5bi	46	26	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	46	27	cost	cost	NN
work_myfomrpabnam7f4o57fxudm5bi	46	28	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	46	29	increased	increase	VBD
work_myfomrpabnam7f4o57fxudm5bi	46	30	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	46	31	only	only	RB
work_myfomrpabnam7f4o57fxudm5bi	46	32	58.1	58.1	CD
work_myfomrpabnam7f4o57fxudm5bi	46	33	%	%	NN
work_myfomrpabnam7f4o57fxudm5bi	46	34	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	46	35	2012	2012	CD
work_myfomrpabnam7f4o57fxudm5bi	46	36	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	46	37	2013	2013	CD
work_myfomrpabnam7f4o57fxudm5bi	46	38	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	46	39	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	46	40	less	less	JJR
work_myfomrpabnam7f4o57fxudm5bi	46	41	than	than	IN
work_myfomrpabnam7f4o57fxudm5bi	46	42	one-	one-	JJ
work_myfomrpabnam7f4o57fxudm5bi	46	43	third	third	NN
work_myfomrpabnam7f4o57fxudm5bi	46	44	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	46	45	patients	patient	NNS
work_myfomrpabnam7f4o57fxudm5bi	46	46	prescribed	prescribe	VBD
work_myfomrpabnam7f4o57fxudm5bi	46	47	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	46	48	high	high	JJ
work_myfomrpabnam7f4o57fxudm5bi	46	49	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	46	50	intensity	intensity	NN
work_myfomrpabnam7f4o57fxudm5bi	46	51	statin	statin	NN
work_myfomrpabnam7f4o57fxudm5bi	46	52	drug.22	drug.22	NNP
work_myfomrpabnam7f4o57fxudm5bi	46	53	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	46	54	must	must	MD
work_myfomrpabnam7f4o57fxudm5bi	46	55	pay	pay	VB
work_myfomrpabnam7f4o57fxudm5bi	46	56	attention	attention	NN
work_myfomrpabnam7f4o57fxudm5bi	46	57	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	46	58	just	just	RB
work_myfomrpabnam7f4o57fxudm5bi	46	59	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	46	60	primary	primary	JJ
work_myfomrpabnam7f4o57fxudm5bi	46	61	prevention	prevention	NN
work_myfomrpabnam7f4o57fxudm5bi	46	62	but	but	CC
work_myfomrpabnam7f4o57fxudm5bi	46	63	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	46	64	primordial	primordial	JJ
work_myfomrpabnam7f4o57fxudm5bi	46	65	preventiondthe	preventiondthe	NN
work_myfomrpabnam7f4o57fxudm5bi	46	66	prevention	prevention	NN
work_myfomrpabnam7f4o57fxudm5bi	46	67	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	46	68	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	46	69	appearance	appearance	NN
work_myfomrpabnam7f4o57fxudm5bi	46	70	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	46	71	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	46	72	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	46	73	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	47	1	This	this	DT
work_myfomrpabnam7f4o57fxudm5bi	47	2	leads	lead	VBZ
work_myfomrpabnam7f4o57fxudm5bi	47	3	us	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	47	4	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	47	5	focus	focus	VB
work_myfomrpabnam7f4o57fxudm5bi	47	6	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	47	7	young	young	JJ
work_myfomrpabnam7f4o57fxudm5bi	47	8	adults	adult	NNS
work_myfomrpabnam7f4o57fxudm5bi	47	9	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	47	10	children	child	NNS
work_myfomrpabnam7f4o57fxudm5bi	47	11	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	48	1	Although	although	IN
work_myfomrpabnam7f4o57fxudm5bi	48	2	we	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	48	3	treat	treat	VBP
work_myfomrpabnam7f4o57fxudm5bi	48	4	individuals	individual	NNS
work_myfomrpabnam7f4o57fxudm5bi	48	5	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	48	6	we	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	48	7	must	must	MD
work_myfomrpabnam7f4o57fxudm5bi	48	8	also	also	RB
work_myfomrpabnam7f4o57fxudm5bi	48	9	engage	engage	VB
work_myfomrpabnam7f4o57fxudm5bi	48	10	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	48	11	population	population	NN
work_myfomrpabnam7f4o57fxudm5bi	48	12	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	48	13	based	base	VBN
work_myfomrpabnam7f4o57fxudm5bi	48	14	initiatives	initiative	NNS
work_myfomrpabnam7f4o57fxudm5bi	48	15	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	48	16	improve	improve	VB
work_myfomrpabnam7f4o57fxudm5bi	48	17	community	community	NN
work_myfomrpabnam7f4o57fxudm5bi	48	18	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	48	19	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	48	20	reduce	reduce	VB
work_myfomrpabnam7f4o57fxudm5bi	48	21	socioeconomic	socioeconomic	JJ
work_myfomrpabnam7f4o57fxudm5bi	48	22	disparities	disparity	NNS
work_myfomrpabnam7f4o57fxudm5bi	48	23	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	49	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	49	2	prevalence	prevalence	NN
work_myfomrpabnam7f4o57fxudm5bi	49	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	49	4	both	both	DT
work_myfomrpabnam7f4o57fxudm5bi	49	5	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	49	6	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	49	7	atherosclerosis	atherosclerosis	NN
work_myfomrpabnam7f4o57fxudm5bi	49	8	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	49	9	strongly	strongly	RB
work_myfomrpabnam7f4o57fxudm5bi	49	10	influenced	influence	VBN
work_myfomrpabnam7f4o57fxudm5bi	49	11	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	49	12	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	49	13	determinants	determinant	NNS
work_myfomrpabnam7f4o57fxudm5bi	49	14	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	49	15	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	49	16	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	50	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	50	2	World	World	NNP
work_myfomrpabnam7f4o57fxudm5bi	50	3	Health	Health	NNP
work_myfomrpabnam7f4o57fxudm5bi	50	4	Organization	Organization	NNP
work_myfomrpabnam7f4o57fxudm5bi	50	5	broadly	broadly	RB
work_myfomrpabnam7f4o57fxudm5bi	50	6	defines	define	VBZ
work_myfomrpabnam7f4o57fxudm5bi	50	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	50	8	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	50	9	de-	de-	NN
work_myfomrpabnam7f4o57fxudm5bi	50	10	terminants	terminant	NNS
work_myfomrpabnam7f4o57fxudm5bi	50	11	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	50	12	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	50	13	as	as	IN
work_myfomrpabnam7f4o57fxudm5bi	50	14	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	50	15	circumstances	circumstance	NNS
work_myfomrpabnam7f4o57fxudm5bi	50	16	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	50	17	which	which	WDT
work_myfomrpabnam7f4o57fxudm5bi	50	18	people	people	NNS
work_myfomrpabnam7f4o57fxudm5bi	50	19	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	50	20	born	bear	VBN
work_myfomrpabnam7f4o57fxudm5bi	50	21	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	50	22	grow	grow	VB
work_myfomrpabnam7f4o57fxudm5bi	50	23	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	50	24	live	live	VB
work_myfomrpabnam7f4o57fxudm5bi	50	25	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	50	26	work	work	NN
work_myfomrpabnam7f4o57fxudm5bi	50	27	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	50	28	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	50	29	age	age	NN
work_myfomrpabnam7f4o57fxudm5bi	50	30	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	50	31	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	50	32	systems	system	NNS
work_myfomrpabnam7f4o57fxudm5bi	50	33	put	put	VBN
work_myfomrpabnam7f4o57fxudm5bi	50	34	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	50	35	place	place	NN
work_myfomrpabnam7f4o57fxudm5bi	50	36	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	50	37	deal	deal	VB
work_myfomrpabnam7f4o57fxudm5bi	50	38	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	50	39	illness.23	illness.23	NNP
work_myfomrpabnam7f4o57fxudm5bi	50	40	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	50	41	need	need	VBP
work_myfomrpabnam7f4o57fxudm5bi	50	42	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	50	43	see	see	VB
work_myfomrpabnam7f4o57fxudm5bi	50	44	ASCVD	ASCVD	NNP
work_myfomrpabnam7f4o57fxudm5bi	50	45	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	50	46	this	this	DT
work_myfomrpabnam7f4o57fxudm5bi	50	47	larger	large	JJR
work_myfomrpabnam7f4o57fxudm5bi	50	48	context	context	NN
work_myfomrpabnam7f4o57fxudm5bi	50	49	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	50	50	just	just	RB
work_myfomrpabnam7f4o57fxudm5bi	50	51	as	as	IN
work_myfomrpabnam7f4o57fxudm5bi	50	52	we	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	50	53	have	have	VBP
work_myfomrpabnam7f4o57fxudm5bi	50	54	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	50	55	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	50	56	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	51	1	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	51	2	must	must	MD
work_myfomrpabnam7f4o57fxudm5bi	51	3	shrink	shrink	VB
work_myfomrpabnam7f4o57fxudm5bi	51	4	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	51	5	mountain	mountain	NN
work_myfomrpabnam7f4o57fxudm5bi	51	6	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	51	7	not	not	RB
work_myfomrpabnam7f4o57fxudm5bi	51	8	just	just	RB
work_myfomrpabnam7f4o57fxudm5bi	51	9	have	have	VB
work_myfomrpabnam7f4o57fxudm5bi	51	10	it	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	51	11	move	move	VB
work_myfomrpabnam7f4o57fxudm5bi	51	12	somewhere	somewhere	RB
work_myfomrpabnam7f4o57fxudm5bi	51	13	else	else	RB
work_myfomrpabnam7f4o57fxudm5bi	51	14	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	52	1	Disclosures	Disclosures	NNP
work_myfomrpabnam7f4o57fxudm5bi	52	2	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	52	3	author	author	NN
work_myfomrpabnam7f4o57fxudm5bi	52	4	has	have	VBZ
work_myfomrpabnam7f4o57fxudm5bi	52	5	no	no	DT
work_myfomrpabnam7f4o57fxudm5bi	52	6	conflicts	conflict	NNS
work_myfomrpabnam7f4o57fxudm5bi	52	7	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	52	8	interest	interest	NN
work_myfomrpabnam7f4o57fxudm5bi	52	9	to	to	TO
work_myfomrpabnam7f4o57fxudm5bi	52	10	disclose	disclose	VB
work_myfomrpabnam7f4o57fxudm5bi	52	11	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	53	1	References	reference	NNS
work_myfomrpabnam7f4o57fxudm5bi	53	2	1	1	CD
work_myfomrpabnam7f4o57fxudm5bi	53	3	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	54	1	Crofton	Crofton	NNP
work_myfomrpabnam7f4o57fxudm5bi	54	2	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	54	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	54	4	Mitchison	Mitchison	NNP
work_myfomrpabnam7f4o57fxudm5bi	54	5	DA	DA	NNP
work_myfomrpabnam7f4o57fxudm5bi	54	6	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	55	1	Streptomycin	streptomycin	JJ
work_myfomrpabnam7f4o57fxudm5bi	55	2	treatment	treatment	NN
work_myfomrpabnam7f4o57fxudm5bi	55	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	55	4	pulmonary	pulmonary	JJ
work_myfomrpabnam7f4o57fxudm5bi	55	5	tuber-	tuber-	JJ
work_myfomrpabnam7f4o57fxudm5bi	55	6	culosis	culosis	NN
work_myfomrpabnam7f4o57fxudm5bi	55	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	56	1	Br	br	UH
work_myfomrpabnam7f4o57fxudm5bi	56	2	Med	Med	NNP
work_myfomrpabnam7f4o57fxudm5bi	56	3	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	56	4	1948;2:769	1948;2:769	CD
work_myfomrpabnam7f4o57fxudm5bi	56	5	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	56	6	82	82	CD
work_myfomrpabnam7f4o57fxudm5bi	56	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	57	1	2	2	LS
work_myfomrpabnam7f4o57fxudm5bi	57	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	58	1	Herrick	Herrick	NNP
work_myfomrpabnam7f4o57fxudm5bi	58	2	JB	JB	NNP
work_myfomrpabnam7f4o57fxudm5bi	58	3	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	59	1	Clinical	clinical	JJ
work_myfomrpabnam7f4o57fxudm5bi	59	2	features	feature	NNS
work_myfomrpabnam7f4o57fxudm5bi	59	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	59	4	sudden	sudden	JJ
work_myfomrpabnam7f4o57fxudm5bi	59	5	obstruction	obstruction	NN
work_myfomrpabnam7f4o57fxudm5bi	59	6	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	59	7	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	59	8	arteries	artery	NNS
work_myfomrpabnam7f4o57fxudm5bi	59	9	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	60	1	JAMA	JAMA	NNP
work_myfomrpabnam7f4o57fxudm5bi	60	2	1912;59:2015	1912;59:2015	CD
work_myfomrpabnam7f4o57fxudm5bi	60	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	60	4	20	20	CD
work_myfomrpabnam7f4o57fxudm5bi	60	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	61	1	296	296	CD
work_myfomrpabnam7f4o57fxudm5bi	61	2	Canadian	Canadian	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	3	Journal	Journal	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	4	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	61	5	Cardiology	Cardiology	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	6	Volume	Volume	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	7	33	33	CD
work_myfomrpabnam7f4o57fxudm5bi	61	8	2017	2017	CD
work_myfomrpabnam7f4o57fxudm5bi	61	9	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref1	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref1	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	10	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref1	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref1	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	11	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref2	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref2	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	12	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref2	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref2	NNP
work_myfomrpabnam7f4o57fxudm5bi	61	13	3	3	CD
work_myfomrpabnam7f4o57fxudm5bi	61	14	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	62	1	Walker	Walker	NNP
work_myfomrpabnam7f4o57fxudm5bi	62	2	WJ	WJ	NNP
work_myfomrpabnam7f4o57fxudm5bi	62	3	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	63	1	Changing	change	VBG
work_myfomrpabnam7f4o57fxudm5bi	63	2	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	63	3	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	63	4	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	63	5	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	63	6	style	style	NN
work_myfomrpabnam7f4o57fxudm5bi	63	7	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	63	8	declining	decline	VBG
work_myfomrpabnam7f4o57fxudm5bi	63	9	vascular	vascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	63	10	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	63	11	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	63	12	cause	cause	NN
work_myfomrpabnam7f4o57fxudm5bi	63	13	or	or	CC
work_myfomrpabnam7f4o57fxudm5bi	63	14	coincidence	coincidence	NN
work_myfomrpabnam7f4o57fxudm5bi	63	15	?	?	.
work_myfomrpabnam7f4o57fxudm5bi	64	1	N	N	NNP
work_myfomrpabnam7f4o57fxudm5bi	64	2	Engl	Engl	NNP
work_myfomrpabnam7f4o57fxudm5bi	64	3	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	64	4	Med	Med	NNP
work_myfomrpabnam7f4o57fxudm5bi	64	5	1977;297:163	1977;297:163	CD
work_myfomrpabnam7f4o57fxudm5bi	64	6	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	64	7	5	5	CD
work_myfomrpabnam7f4o57fxudm5bi	64	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	65	1	4	4	LS
work_myfomrpabnam7f4o57fxudm5bi	65	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	66	1	Ford	Ford	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	2	ES	ES	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	66	4	Roger	Roger	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	5	VL	VL	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	66	7	Dunlay	Dunlay	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	8	SM	SM	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	66	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	66	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	67	1	Challenges	challenge	NNS
work_myfomrpabnam7f4o57fxudm5bi	67	2	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	67	3	ascertaining	ascertain	VBG
work_myfomrpabnam7f4o57fxudm5bi	67	4	national	national	JJ
work_myfomrpabnam7f4o57fxudm5bi	67	5	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	67	6	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	67	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	67	8	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	67	9	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	67	10	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	67	11	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	67	12	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	67	13	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	67	14	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	67	15	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	67	16	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	67	17	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	68	1	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	68	2	Am	Am	NNP
work_myfomrpabnam7f4o57fxudm5bi	68	3	Heart	Heart	NNP
work_myfomrpabnam7f4o57fxudm5bi	68	4	Assoc	Assoc	NNP
work_myfomrpabnam7f4o57fxudm5bi	68	5	2014;3	2014;3	VBZ
work_myfomrpabnam7f4o57fxudm5bi	68	6	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	68	7	e001097	e001097	NN
work_myfomrpabnam7f4o57fxudm5bi	68	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	69	1	5	5	CD
work_myfomrpabnam7f4o57fxudm5bi	69	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	70	1	Tu	Tu	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	2	JV	JV	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	70	4	Khan	Khan	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	5	AM	AM	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	70	7	Ng	Ng	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	8	K	K	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	70	10	Chu	Chu	NNP
work_myfomrpabnam7f4o57fxudm5bi	70	11	A.	a.	NN
work_myfomrpabnam7f4o57fxudm5bi	71	1	Recent	recent	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	2	temporal	temporal	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	3	changes	change	NNS
work_myfomrpabnam7f4o57fxudm5bi	71	4	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	71	5	athero-	athero-	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	6	sclerotic	sclerotic	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	7	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	8	diseases	disease	NNS
work_myfomrpabnam7f4o57fxudm5bi	71	9	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	71	10	Ontario	Ontario	NNP
work_myfomrpabnam7f4o57fxudm5bi	71	11	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	71	12	clinical	clinical	JJ
work_myfomrpabnam7f4o57fxudm5bi	71	13	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	71	14	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	71	15	systems	system	NNS
work_myfomrpabnam7f4o57fxudm5bi	71	16	impact	impact	NN
work_myfomrpabnam7f4o57fxudm5bi	71	17	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	72	1	Can	Can	MD
work_myfomrpabnam7f4o57fxudm5bi	72	2	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	72	3	Cardiol	Cardiol	NNP
work_myfomrpabnam7f4o57fxudm5bi	72	4	2017;33:378	2017;33:378	CD
work_myfomrpabnam7f4o57fxudm5bi	72	5	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	72	6	84	84	CD
work_myfomrpabnam7f4o57fxudm5bi	72	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	73	1	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	73	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	74	1	Hunink	Hunink	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	2	MG	MG	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	74	4	Goldman	Goldman	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	5	L	L	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	74	7	Tosteson	Tosteson	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	8	AN	AN	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	74	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	74	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	75	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	75	2	recent	recent	JJ
work_myfomrpabnam7f4o57fxudm5bi	75	3	decline	decline	NN
work_myfomrpabnam7f4o57fxudm5bi	75	4	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	75	5	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	75	6	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	75	7	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	75	8	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	75	9	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	75	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	75	11	1980	1980	CD
work_myfomrpabnam7f4o57fxudm5bi	75	12	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	75	13	1990	1990	CD
work_myfomrpabnam7f4o57fxudm5bi	75	14	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	75	15	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	75	16	effect	effect	NN
work_myfomrpabnam7f4o57fxudm5bi	75	17	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	75	18	secular	secular	JJ
work_myfomrpabnam7f4o57fxudm5bi	75	19	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	75	20	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	75	21	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	75	22	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	75	23	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	75	24	treatment	treatment	NN
work_myfomrpabnam7f4o57fxudm5bi	75	25	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	76	1	JAMA	JAMA	NNP
work_myfomrpabnam7f4o57fxudm5bi	76	2	1997;277:535	1997;277:535	CD
work_myfomrpabnam7f4o57fxudm5bi	76	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	76	4	42	42	CD
work_myfomrpabnam7f4o57fxudm5bi	76	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	77	1	7	7	LS
work_myfomrpabnam7f4o57fxudm5bi	77	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	78	1	Mannsverk	Mannsverk	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	2	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	78	4	Wilsgaard	Wilsgaard	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	5	T	T	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	78	7	Mathiesen	Mathiesen	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	8	EB	EB	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	78	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	78	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	79	1	Trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	79	2	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	79	3	modifiable	modifiable	JJ
work_myfomrpabnam7f4o57fxudm5bi	79	4	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	79	5	factors	factor	NNS
work_myfomrpabnam7f4o57fxudm5bi	79	6	are	be	VBP
work_myfomrpabnam7f4o57fxudm5bi	79	7	associated	associate	VBN
work_myfomrpabnam7f4o57fxudm5bi	79	8	with	with	IN
work_myfomrpabnam7f4o57fxudm5bi	79	9	declining	decline	VBG
work_myfomrpabnam7f4o57fxudm5bi	79	10	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	79	11	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	79	12	hospitalized	hospitalized	JJ
work_myfomrpabnam7f4o57fxudm5bi	79	13	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	79	14	nonhospitalized	nonhospitalize	VBD
work_myfomrpabnam7f4o57fxudm5bi	79	15	acute	acute	JJ
work_myfomrpabnam7f4o57fxudm5bi	79	16	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	79	17	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	79	18	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	79	19	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	79	20	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	79	21	population	population	NN
work_myfomrpabnam7f4o57fxudm5bi	79	22	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	80	1	Circulation	circulation	NN
work_myfomrpabnam7f4o57fxudm5bi	80	2	2016;133:74	2016;133:74	NNP
work_myfomrpabnam7f4o57fxudm5bi	80	3	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	80	4	81	81	CD
work_myfomrpabnam7f4o57fxudm5bi	80	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	81	1	8	8	LS
work_myfomrpabnam7f4o57fxudm5bi	81	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	82	1	Egan	Egan	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	2	BM	BM	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	82	4	Li	Li	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	5	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	82	7	White	White	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	8	K	K	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	82	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	82	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	83	1	2013	2013	CD
work_myfomrpabnam7f4o57fxudm5bi	83	2	ACC	ACC	NNP
work_myfomrpabnam7f4o57fxudm5bi	83	3	/	/	SYM
work_myfomrpabnam7f4o57fxudm5bi	83	4	AHA	AHA	NNP
work_myfomrpabnam7f4o57fxudm5bi	83	5	cholesterol	cholesterol	NN
work_myfomrpabnam7f4o57fxudm5bi	83	6	guideline	guideline	NN
work_myfomrpabnam7f4o57fxudm5bi	83	7	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	83	8	implications	implication	NNS
work_myfomrpabnam7f4o57fxudm5bi	83	9	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	83	10	Healthy	Healthy	NNP
work_myfomrpabnam7f4o57fxudm5bi	83	11	People	People	NNPS
work_myfomrpabnam7f4o57fxudm5bi	83	12	2020	2020	CD
work_myfomrpabnam7f4o57fxudm5bi	83	13	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	83	14	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	83	15	pre-	pre-	NNP
work_myfomrpabnam7f4o57fxudm5bi	83	16	vention	vention	NN
work_myfomrpabnam7f4o57fxudm5bi	83	17	goals	goal	NNS
work_myfomrpabnam7f4o57fxudm5bi	83	18	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	84	1	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	84	2	Am	Am	NNP
work_myfomrpabnam7f4o57fxudm5bi	84	3	Heart	Heart	NNP
work_myfomrpabnam7f4o57fxudm5bi	84	4	Assoc	Assoc	NNP
work_myfomrpabnam7f4o57fxudm5bi	84	5	2016;5:8	2016;5:8	CD
work_myfomrpabnam7f4o57fxudm5bi	84	6	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	85	1	9	9	CD
work_myfomrpabnam7f4o57fxudm5bi	85	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	86	1	Dye	Dye	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	2	C	C	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	86	4	Scheele	Scheele	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	5	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	86	7	Dolin	Dolin	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	8	P	P	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	86	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	86	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	87	1	Consensus	consensus	NN
work_myfomrpabnam7f4o57fxudm5bi	87	2	statement	statement	NN
work_myfomrpabnam7f4o57fxudm5bi	87	3	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	88	1	Global	global	JJ
work_myfomrpabnam7f4o57fxudm5bi	88	2	burden	burden	NN
work_myfomrpabnam7f4o57fxudm5bi	88	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	88	4	tuberculosis	tuberculosis	NN
work_myfomrpabnam7f4o57fxudm5bi	88	5	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	88	6	estimated	estimate	VBN
work_myfomrpabnam7f4o57fxudm5bi	88	7	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	88	8	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	88	9	prevalence	prevalence	NN
work_myfomrpabnam7f4o57fxudm5bi	88	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	88	11	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	88	12	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	88	13	by	by	IN
work_myfomrpabnam7f4o57fxudm5bi	88	14	country	country	NN
work_myfomrpabnam7f4o57fxudm5bi	88	15	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	89	1	WHO	who	WP
work_myfomrpabnam7f4o57fxudm5bi	89	2	Global	global	JJ
work_myfomrpabnam7f4o57fxudm5bi	89	3	Surveillance	surveillance	NN
work_myfomrpabnam7f4o57fxudm5bi	89	4	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	89	5	Monitoring	Monitoring	NNP
work_myfomrpabnam7f4o57fxudm5bi	89	6	Project	Project	NNP
work_myfomrpabnam7f4o57fxudm5bi	89	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	90	1	JAMA	JAMA	NNP
work_myfomrpabnam7f4o57fxudm5bi	90	2	1999;282	1999;282	CD
work_myfomrpabnam7f4o57fxudm5bi	90	3	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	90	4	677	677	CD
work_myfomrpabnam7f4o57fxudm5bi	90	5	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	90	6	86	86	CD
work_myfomrpabnam7f4o57fxudm5bi	90	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	91	1	10	10	CD
work_myfomrpabnam7f4o57fxudm5bi	91	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	92	1	Ford	Ford	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	2	ES	ES	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	92	4	Capewell	Capewell	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	5	S.	S.	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	6	Coronary	Coronary	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	7	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	92	8	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	92	9	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	92	10	among	among	IN
work_myfomrpabnam7f4o57fxudm5bi	92	11	young	young	JJ
work_myfomrpabnam7f4o57fxudm5bi	92	12	adults	adult	NNS
work_myfomrpabnam7f4o57fxudm5bi	92	13	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	92	14	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	92	15	U.S.	U.S.	NNP
work_myfomrpabnam7f4o57fxudm5bi	92	16	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	92	17	1980	1980	CD
work_myfomrpabnam7f4o57fxudm5bi	92	18	through	through	IN
work_myfomrpabnam7f4o57fxudm5bi	92	19	2002	2002	CD
work_myfomrpabnam7f4o57fxudm5bi	92	20	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	92	21	concealed	conceal	VBN
work_myfomrpabnam7f4o57fxudm5bi	92	22	leveling	leveling	NN
work_myfomrpabnam7f4o57fxudm5bi	92	23	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	92	24	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	92	25	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	92	26	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	93	1	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	93	2	Am	Am	NNP
work_myfomrpabnam7f4o57fxudm5bi	93	3	Coll	Coll	NNP
work_myfomrpabnam7f4o57fxudm5bi	93	4	Cardiol	Cardiol	NNP
work_myfomrpabnam7f4o57fxudm5bi	93	5	2007;50:2128	2007;50:2128	CD
work_myfomrpabnam7f4o57fxudm5bi	93	6	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	93	7	32	32	CD
work_myfomrpabnam7f4o57fxudm5bi	93	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	94	1	11	11	CD
work_myfomrpabnam7f4o57fxudm5bi	94	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	95	1	O’Flaherty	O’Flaherty	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	2	M	M	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	95	4	Ford	Ford	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	5	E	E	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	95	7	Allender	Allender	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	8	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	95	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	95	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	96	1	Coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	96	2	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	96	3	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	96	4	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	96	5	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	96	6	England	England	NNP
work_myfomrpabnam7f4o57fxudm5bi	96	7	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	96	8	Wales	Wales	NNP
work_myfomrpabnam7f4o57fxudm5bi	96	9	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	96	10	1984	1984	CD
work_myfomrpabnam7f4o57fxudm5bi	96	11	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	96	12	2004	2004	CD
work_myfomrpabnam7f4o57fxudm5bi	96	13	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	96	14	concealed	conceal	VBN
work_myfomrpabnam7f4o57fxudm5bi	96	15	levelling	levelling	NN
work_myfomrpabnam7f4o57fxudm5bi	96	16	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	96	17	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	96	18	rates	rate	NNS
work_myfomrpabnam7f4o57fxudm5bi	96	19	among	among	IN
work_myfomrpabnam7f4o57fxudm5bi	96	20	young	young	JJ
work_myfomrpabnam7f4o57fxudm5bi	96	21	adults	adult	NNS
work_myfomrpabnam7f4o57fxudm5bi	96	22	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	97	1	Heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	97	2	2008;94:178	2008;94:178	CD
work_myfomrpabnam7f4o57fxudm5bi	97	3	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	97	4	81	81	CD
work_myfomrpabnam7f4o57fxudm5bi	97	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	98	1	12	12	CD
work_myfomrpabnam7f4o57fxudm5bi	98	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	99	1	Nedkoff	Nedkoff	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	2	LJ	LJ	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	99	4	Briffa	Briffa	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	5	TG	TG	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	99	7	Preen	Preen	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	8	DB	DB	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	99	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	99	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	100	1	Age-	age-	CD
work_myfomrpabnam7f4o57fxudm5bi	100	2	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	100	3	sex	sex	NN
work_myfomrpabnam7f4o57fxudm5bi	100	4	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	100	5	specific	specific	JJ
work_myfomrpabnam7f4o57fxudm5bi	100	6	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	100	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	100	8	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	100	9	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	100	10	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	100	11	hospitalized	hospitalized	JJ
work_myfomrpabnam7f4o57fxudm5bi	100	12	acute	acute	JJ
work_myfomrpabnam7f4o57fxudm5bi	100	13	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	100	14	syndromes	syndrome	VBZ
work_myfomrpabnam7f4o57fxudm5bi	100	15	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	100	16	Western	Western	NNP
work_myfomrpabnam7f4o57fxudm5bi	100	17	Australia	Australia	NNP
work_myfomrpabnam7f4o57fxudm5bi	100	18	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	101	1	Circ	Circ	NNP
work_myfomrpabnam7f4o57fxudm5bi	101	2	Cardiovasc	Cardiovasc	NNP
work_myfomrpabnam7f4o57fxudm5bi	101	3	Qual	Qual	NNP
work_myfomrpabnam7f4o57fxudm5bi	101	4	Outcomes	Outcomes	NNP
work_myfomrpabnam7f4o57fxudm5bi	101	5	2011;4:557	2011;4:557	CD
work_myfomrpabnam7f4o57fxudm5bi	101	6	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	101	7	64	64	CD
work_myfomrpabnam7f4o57fxudm5bi	101	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	102	1	13	13	CD
work_myfomrpabnam7f4o57fxudm5bi	102	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	103	1	Wilmot	Wilmot	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	2	KA	KA	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	103	4	O’Flaherty	O’Flaherty	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	5	M	M	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	103	7	Capewell	Capewell	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	8	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	103	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	103	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	104	1	Coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	104	2	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	104	3	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	104	4	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	104	5	declines	decline	NNS
work_myfomrpabnam7f4o57fxudm5bi	104	6	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	104	7	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	104	8	United	United	NNP
work_myfomrpabnam7f4o57fxudm5bi	104	9	States	States	NNP
work_myfomrpabnam7f4o57fxudm5bi	104	10	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	104	11	1979	1979	CD
work_myfomrpabnam7f4o57fxudm5bi	104	12	through	through	IN
work_myfomrpabnam7f4o57fxudm5bi	104	13	2011	2011	CD
work_myfomrpabnam7f4o57fxudm5bi	104	14	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	104	15	evidence	evidence	NN
work_myfomrpabnam7f4o57fxudm5bi	104	16	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	104	17	stagnation	stagnation	NN
work_myfomrpabnam7f4o57fxudm5bi	104	18	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	104	19	young	young	JJ
work_myfomrpabnam7f4o57fxudm5bi	104	20	adults	adult	NNS
work_myfomrpabnam7f4o57fxudm5bi	104	21	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	104	22	especially	especially	RB
work_myfomrpabnam7f4o57fxudm5bi	104	23	women	woman	NNS
work_myfomrpabnam7f4o57fxudm5bi	104	24	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	105	1	Circulation	circulation	NN
work_myfomrpabnam7f4o57fxudm5bi	105	2	2015;132:997	2015;132:997	CD
work_myfomrpabnam7f4o57fxudm5bi	105	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	105	4	1002	1002	CD
work_myfomrpabnam7f4o57fxudm5bi	105	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	106	1	14	14	CD
work_myfomrpabnam7f4o57fxudm5bi	106	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	107	1	Murray	Murray	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	2	CJL	CJL	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	107	4	Vos	Vos	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	5	T	T	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	107	7	Lozano	Lozano	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	8	R	R	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	107	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	107	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	108	1	Disability	disability	NN
work_myfomrpabnam7f4o57fxudm5bi	108	2	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	108	3	adjusted	adjust	VBN
work_myfomrpabnam7f4o57fxudm5bi	108	4	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	108	5	years	year	NNS
work_myfomrpabnam7f4o57fxudm5bi	108	6	(	(	-LRB-
work_myfomrpabnam7f4o57fxudm5bi	108	7	DALYs	DALYs	NNPS
work_myfomrpabnam7f4o57fxudm5bi	108	8	)	)	-RRB-
work_myfomrpabnam7f4o57fxudm5bi	108	9	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	108	10	291	291	CD
work_myfomrpabnam7f4o57fxudm5bi	108	11	diseases	disease	NNS
work_myfomrpabnam7f4o57fxudm5bi	108	12	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	108	13	injuries	injury	NNS
work_myfomrpabnam7f4o57fxudm5bi	108	14	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	108	15	21	21	CD
work_myfomrpabnam7f4o57fxudm5bi	108	16	regions	region	NNS
work_myfomrpabnam7f4o57fxudm5bi	108	17	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	108	18	1990	1990	CD
work_myfomrpabnam7f4o57fxudm5bi	108	19	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	108	20	2010	2010	CD
work_myfomrpabnam7f4o57fxudm5bi	108	21	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	108	22	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	108	23	sys-	sys-	RB
work_myfomrpabnam7f4o57fxudm5bi	108	24	tematic	tematic	JJ
work_myfomrpabnam7f4o57fxudm5bi	108	25	analysis	analysis	NN
work_myfomrpabnam7f4o57fxudm5bi	108	26	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	108	27	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	108	28	Global	Global	NNP
work_myfomrpabnam7f4o57fxudm5bi	108	29	Burden	Burden	NNP
work_myfomrpabnam7f4o57fxudm5bi	108	30	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	108	31	Disease	Disease	NNP
work_myfomrpabnam7f4o57fxudm5bi	108	32	Study	Study	NNP
work_myfomrpabnam7f4o57fxudm5bi	108	33	2010	2010	CD
work_myfomrpabnam7f4o57fxudm5bi	108	34	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	109	1	Lancet	Lancet	NNP
work_myfomrpabnam7f4o57fxudm5bi	109	2	2012;380:2197	2012;380:2197	NNP
work_myfomrpabnam7f4o57fxudm5bi	109	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	109	4	223	223	CD
work_myfomrpabnam7f4o57fxudm5bi	109	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	110	1	15	15	CD
work_myfomrpabnam7f4o57fxudm5bi	110	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	111	1	Yusuf	Yusuf	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	2	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	111	4	Rangarajan	Rangarajan	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	5	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	111	7	Teo	Teo	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	8	K	K	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	111	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	111	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	112	1	Cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	112	2	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	112	3	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	112	4	events	event	NNS
work_myfomrpabnam7f4o57fxudm5bi	112	5	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	112	6	17	17	CD
work_myfomrpabnam7f4o57fxudm5bi	112	7	low-	low-	NN
work_myfomrpabnam7f4o57fxudm5bi	112	8	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	112	9	middle-	middle-	NNP
work_myfomrpabnam7f4o57fxudm5bi	112	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	112	11	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	112	12	high	high	JJ
work_myfomrpabnam7f4o57fxudm5bi	112	13	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	112	14	income	income	NN
work_myfomrpabnam7f4o57fxudm5bi	112	15	countries	country	NNS
work_myfomrpabnam7f4o57fxudm5bi	112	16	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	113	1	N	N	NNP
work_myfomrpabnam7f4o57fxudm5bi	113	2	Engl	Engl	NNP
work_myfomrpabnam7f4o57fxudm5bi	113	3	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	113	4	Med	Med	NNP
work_myfomrpabnam7f4o57fxudm5bi	113	5	2014;371	2014;371	CD
work_myfomrpabnam7f4o57fxudm5bi	113	6	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	113	7	818	818	CD
work_myfomrpabnam7f4o57fxudm5bi	113	8	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	113	9	27	27	CD
work_myfomrpabnam7f4o57fxudm5bi	113	10	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	114	1	16	16	CD
work_myfomrpabnam7f4o57fxudm5bi	114	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	115	1	Wu	Wu	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	2	Y	Y	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	115	4	Benjamin	Benjamin	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	5	EJ	EJ	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	115	7	MacMahon	MacMahon	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	8	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	115	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	115	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	116	1	Prevention	prevention	NN
work_myfomrpabnam7f4o57fxudm5bi	116	2	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	116	3	control	control	NN
work_myfomrpabnam7f4o57fxudm5bi	116	4	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	116	5	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	116	6	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	116	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	116	8	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	116	9	rapidly	rapidly	RB
work_myfomrpabnam7f4o57fxudm5bi	116	10	changing	change	VBG
work_myfomrpabnam7f4o57fxudm5bi	116	11	economy	economy	NN
work_myfomrpabnam7f4o57fxudm5bi	116	12	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	116	13	China	China	NNP
work_myfomrpabnam7f4o57fxudm5bi	116	14	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	117	1	Cir-	Cir-	NNP
work_myfomrpabnam7f4o57fxudm5bi	117	2	culation	culation	NN
work_myfomrpabnam7f4o57fxudm5bi	117	3	2016;133:2545	2016;133:2545	CD
work_myfomrpabnam7f4o57fxudm5bi	117	4	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	117	5	60	60	CD
work_myfomrpabnam7f4o57fxudm5bi	117	6	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	118	1	17	17	CD
work_myfomrpabnam7f4o57fxudm5bi	118	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	119	1	Cheshire	Cheshire	NNP
work_myfomrpabnam7f4o57fxudm5bi	119	2	JA	JA	NNP
work_myfomrpabnam7f4o57fxudm5bi	119	3	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	120	1	Lives	life	NNS
work_myfomrpabnam7f4o57fxudm5bi	120	2	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	120	3	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	120	4	line	line	NN
work_myfomrpabnam7f4o57fxudm5bi	120	5	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	120	6	mapping	map	VBG
work_myfomrpabnam7f4o57fxudm5bi	120	7	life	life	NN
work_myfomrpabnam7f4o57fxudm5bi	120	8	expectancy	expectancy	NN
work_myfomrpabnam7f4o57fxudm5bi	120	9	along	along	IN
work_myfomrpabnam7f4o57fxudm5bi	120	10	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	120	11	London	London	NNP
work_myfomrpabnam7f4o57fxudm5bi	120	12	tube	tube	NN
work_myfomrpabnam7f4o57fxudm5bi	120	13	network	network	NN
work_myfomrpabnam7f4o57fxudm5bi	120	14	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	121	1	Environment	Environment	NNP
work_myfomrpabnam7f4o57fxudm5bi	121	2	Planning	Planning	NNP
work_myfomrpabnam7f4o57fxudm5bi	121	3	A	a	DT
work_myfomrpabnam7f4o57fxudm5bi	121	4	2012;44:7	2012;44:7	CD
work_myfomrpabnam7f4o57fxudm5bi	121	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	122	1	18	18	CD
work_myfomrpabnam7f4o57fxudm5bi	122	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	123	1	Marmot	Marmot	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	2	MG	MG	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	123	4	Shipley	Shipley	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	5	MJ	MJ	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	123	7	Rose	Rose	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	8	G	G	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	123	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	123	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	124	1	Inequalities	inequality	NNS
work_myfomrpabnam7f4o57fxudm5bi	124	2	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	124	3	death	death	NN
work_myfomrpabnam7f4o57fxudm5bi	124	4	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	124	5	specific	specific	JJ
work_myfomrpabnam7f4o57fxudm5bi	124	6	explanations	explanation	NNS
work_myfomrpabnam7f4o57fxudm5bi	124	7	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	124	8	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	124	9	general	general	JJ
work_myfomrpabnam7f4o57fxudm5bi	124	10	pattern	pattern	NN
work_myfomrpabnam7f4o57fxudm5bi	124	11	?	?	.
work_myfomrpabnam7f4o57fxudm5bi	125	1	Lancet	Lancet	NNP
work_myfomrpabnam7f4o57fxudm5bi	125	2	1984;1:1003	1984;1:1003	CD
work_myfomrpabnam7f4o57fxudm5bi	125	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	125	4	6	6	CD
work_myfomrpabnam7f4o57fxudm5bi	125	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	126	1	19	19	CD
work_myfomrpabnam7f4o57fxudm5bi	126	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	127	1	Diez	Diez	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	2	Roux	Roux	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	3	AV	AV	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	4	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	127	5	Merkin	Merkin	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	6	SS	SS	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	7	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	127	8	Arnett	Arnett	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	9	D	D	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	10	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	127	11	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	12	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	127	13	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	128	1	Neighborhood	neighborhood	NN
work_myfomrpabnam7f4o57fxudm5bi	128	2	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	128	3	residence	residence	NN
work_myfomrpabnam7f4o57fxudm5bi	128	4	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	128	5	incidence	incidence	NN
work_myfomrpabnam7f4o57fxudm5bi	128	6	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	128	7	coronary	coronary	JJ
work_myfomrpabnam7f4o57fxudm5bi	128	8	heart	heart	NN
work_myfomrpabnam7f4o57fxudm5bi	128	9	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	128	10	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	129	1	N	N	NNP
work_myfomrpabnam7f4o57fxudm5bi	129	2	Engl	Engl	NNP
work_myfomrpabnam7f4o57fxudm5bi	129	3	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	129	4	Med	Med	NNP
work_myfomrpabnam7f4o57fxudm5bi	129	5	2001;345:99	2001;345:99	NNP
work_myfomrpabnam7f4o57fxudm5bi	129	6	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	129	7	106	106	CD
work_myfomrpabnam7f4o57fxudm5bi	129	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	130	1	20	20	CD
work_myfomrpabnam7f4o57fxudm5bi	130	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	131	1	Kawachi	Kawachi	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	2	I	I	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	131	4	Colditz	Colditz	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	5	GA	GA	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	131	7	Ascherio	Ascherio	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	8	A	A	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	131	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	131	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	132	1	A	a	DT
work_myfomrpabnam7f4o57fxudm5bi	132	2	prospective	prospective	JJ
work_myfomrpabnam7f4o57fxudm5bi	132	3	study	study	NN
work_myfomrpabnam7f4o57fxudm5bi	132	4	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	132	5	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	132	6	networks	network	NNS
work_myfomrpabnam7f4o57fxudm5bi	132	7	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	132	8	relation	relation	NN
work_myfomrpabnam7f4o57fxudm5bi	132	9	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	132	10	total	total	JJ
work_myfomrpabnam7f4o57fxudm5bi	132	11	mortality	mortality	NN
work_myfomrpabnam7f4o57fxudm5bi	132	12	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	132	13	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	132	14	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	132	15	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	132	16	men	man	NNS
work_myfomrpabnam7f4o57fxudm5bi	132	17	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	132	18	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	132	19	USA	USA	NNP
work_myfomrpabnam7f4o57fxudm5bi	132	20	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	133	1	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	133	2	Epidemiol	Epidemiol	NNP
work_myfomrpabnam7f4o57fxudm5bi	133	3	Community	Community	NNP
work_myfomrpabnam7f4o57fxudm5bi	133	4	Health	Health	NNP
work_myfomrpabnam7f4o57fxudm5bi	133	5	1996;50:245	1996;50:245	CD
work_myfomrpabnam7f4o57fxudm5bi	133	6	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	133	7	51	51	CD
work_myfomrpabnam7f4o57fxudm5bi	133	8	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	134	1	21	21	CD
work_myfomrpabnam7f4o57fxudm5bi	134	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	135	1	Havranek	Havranek	NNS
work_myfomrpabnam7f4o57fxudm5bi	135	2	EP	EP	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	135	4	Mujahid	Mujahid	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	5	MS	MS	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	135	7	Barr	Barr	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	8	DA	DA	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	135	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	135	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	136	1	Social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	136	2	determinants	determinant	NNS
work_myfomrpabnam7f4o57fxudm5bi	136	3	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	136	4	risk	risk	NN
work_myfomrpabnam7f4o57fxudm5bi	136	5	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	136	6	outcomes	outcome	NNS
work_myfomrpabnam7f4o57fxudm5bi	136	7	for	for	IN
work_myfomrpabnam7f4o57fxudm5bi	136	8	cardiovascular	cardiovascular	JJ
work_myfomrpabnam7f4o57fxudm5bi	136	9	disease	disease	NN
work_myfomrpabnam7f4o57fxudm5bi	136	10	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	137	1	A	a	DT
work_myfomrpabnam7f4o57fxudm5bi	137	2	scientific	scientific	JJ
work_myfomrpabnam7f4o57fxudm5bi	137	3	statement	statement	NN
work_myfomrpabnam7f4o57fxudm5bi	137	4	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	137	5	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	137	6	American	American	NNP
work_myfomrpabnam7f4o57fxudm5bi	137	7	Heart	Heart	NNP
work_myfomrpabnam7f4o57fxudm5bi	137	8	Association	Association	NNP
work_myfomrpabnam7f4o57fxudm5bi	137	9	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	138	1	Circulation	circulation	NN
work_myfomrpabnam7f4o57fxudm5bi	138	2	2015;132:873	2015;132:873	CD
work_myfomrpabnam7f4o57fxudm5bi	138	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	138	4	98	98	CD
work_myfomrpabnam7f4o57fxudm5bi	138	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	139	1	22	22	CD
work_myfomrpabnam7f4o57fxudm5bi	139	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	140	1	Salami	Salami	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	2	JA	JA	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	140	4	Warraich	Warraich	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	5	H	H	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	140	7	Valero	Valero	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	8	-	-	HYPH
work_myfomrpabnam7f4o57fxudm5bi	140	9	Elizondo	Elizondo	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	10	J	J	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	11	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	140	12	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	13	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	140	14	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	141	1	National	national	JJ
work_myfomrpabnam7f4o57fxudm5bi	141	2	trends	trend	NNS
work_myfomrpabnam7f4o57fxudm5bi	141	3	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	141	4	statin	statin	NN
work_myfomrpabnam7f4o57fxudm5bi	141	5	use	use	NN
work_myfomrpabnam7f4o57fxudm5bi	141	6	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	141	7	expenditures	expenditure	NNS
work_myfomrpabnam7f4o57fxudm5bi	141	8	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	141	9	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	141	10	US	US	NNP
work_myfomrpabnam7f4o57fxudm5bi	141	11	adult	adult	NN
work_myfomrpabnam7f4o57fxudm5bi	141	12	population	population	NN
work_myfomrpabnam7f4o57fxudm5bi	141	13	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	141	14	2002	2002	CD
work_myfomrpabnam7f4o57fxudm5bi	141	15	to	to	IN
work_myfomrpabnam7f4o57fxudm5bi	141	16	2013	2013	CD
work_myfomrpabnam7f4o57fxudm5bi	141	17	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	141	18	insights	insight	NNS
work_myfomrpabnam7f4o57fxudm5bi	141	19	from	from	IN
work_myfomrpabnam7f4o57fxudm5bi	141	20	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	141	21	Medical	Medical	NNP
work_myfomrpabnam7f4o57fxudm5bi	141	22	Expenditure	Expenditure	NNP
work_myfomrpabnam7f4o57fxudm5bi	141	23	Panel	Panel	NNP
work_myfomrpabnam7f4o57fxudm5bi	141	24	Survey	Survey	NNP
work_myfomrpabnam7f4o57fxudm5bi	141	25	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	142	1	JAMA	JAMA	NNP
work_myfomrpabnam7f4o57fxudm5bi	142	2	Cardiol	Cardiol	NNP
work_myfomrpabnam7f4o57fxudm5bi	142	3	2017;2:56	2017;2:56	CD
work_myfomrpabnam7f4o57fxudm5bi	142	4	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	142	5	65	65	CD
work_myfomrpabnam7f4o57fxudm5bi	142	6	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	143	1	23	23	CD
work_myfomrpabnam7f4o57fxudm5bi	143	2	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	144	1	Marmot	Marmot	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	2	M	M	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	3	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	144	4	Friel	Friel	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	5	S	S	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	6	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	144	7	Bell	Bell	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	8	R	R	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	9	,	,	,
work_myfomrpabnam7f4o57fxudm5bi	144	10	et	et	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	11	al	al	NNP
work_myfomrpabnam7f4o57fxudm5bi	144	12	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	145	1	Commission	Commission	NNP
work_myfomrpabnam7f4o57fxudm5bi	145	2	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	145	3	Social	Social	NNP
work_myfomrpabnam7f4o57fxudm5bi	145	4	Determinants	Determinants	NNPS
work_myfomrpabnam7f4o57fxudm5bi	145	5	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	145	6	Health	Health	NNP
work_myfomrpabnam7f4o57fxudm5bi	145	7	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	146	1	Closing	close	VBG
work_myfomrpabnam7f4o57fxudm5bi	146	2	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	146	3	gap	gap	NN
work_myfomrpabnam7f4o57fxudm5bi	146	4	in	in	IN
work_myfomrpabnam7f4o57fxudm5bi	146	5	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	146	6	generation	generation	NN
work_myfomrpabnam7f4o57fxudm5bi	146	7	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	146	8	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	146	9	equity	equity	NN
work_myfomrpabnam7f4o57fxudm5bi	146	10	through	through	IN
work_myfomrpabnam7f4o57fxudm5bi	146	11	action	action	NN
work_myfomrpabnam7f4o57fxudm5bi	146	12	on	on	IN
work_myfomrpabnam7f4o57fxudm5bi	146	13	the	the	DT
work_myfomrpabnam7f4o57fxudm5bi	146	14	social	social	JJ
work_myfomrpabnam7f4o57fxudm5bi	146	15	determinants	determinant	NNS
work_myfomrpabnam7f4o57fxudm5bi	146	16	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	146	17	health	health	NN
work_myfomrpabnam7f4o57fxudm5bi	146	18	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	147	1	Lancet	Lancet	NNP
work_myfomrpabnam7f4o57fxudm5bi	147	2	2008;372:1661	2008;372:1661	CD
work_myfomrpabnam7f4o57fxudm5bi	147	3	-	-	SYM
work_myfomrpabnam7f4o57fxudm5bi	147	4	9	9	CD
work_myfomrpabnam7f4o57fxudm5bi	147	5	.	.	.
work_myfomrpabnam7f4o57fxudm5bi	148	1	David	David	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	2	D.	D.	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	3	Waters	Waters	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	4	297	297	CD
work_myfomrpabnam7f4o57fxudm5bi	148	5	Rise	Rise	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	6	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	148	7	Fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	148	8	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	148	9	Tuberculosis	Tuberculosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	10	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	148	11	Atherosclerosis	Atherosclerosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	12	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref3	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref3	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	13	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref3	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref3	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	14	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	15	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	16	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref4	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	17	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	18	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	19	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref5	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	20	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	21	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	22	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref6	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	23	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	24	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	25	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	26	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref7	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	27	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	28	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	29	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref8	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	30	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref9	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref9	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	31	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref9	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref9	UH
work_myfomrpabnam7f4o57fxudm5bi	148	32	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref9	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref9	UH
work_myfomrpabnam7f4o57fxudm5bi	148	33	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref9	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref9	UH
work_myfomrpabnam7f4o57fxudm5bi	148	34	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref10	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref10	UH
work_myfomrpabnam7f4o57fxudm5bi	148	35	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref10	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref10	UH
work_myfomrpabnam7f4o57fxudm5bi	148	36	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref10	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref10	JJ
work_myfomrpabnam7f4o57fxudm5bi	148	37	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref11	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref11	NN
work_myfomrpabnam7f4o57fxudm5bi	148	38	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref11	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref11	NN
work_myfomrpabnam7f4o57fxudm5bi	148	39	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref11	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref11	JJ
work_myfomrpabnam7f4o57fxudm5bi	148	40	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref12	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref12	NN
work_myfomrpabnam7f4o57fxudm5bi	148	41	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref12	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref12	NN
work_myfomrpabnam7f4o57fxudm5bi	148	42	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref12	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref12	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	43	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	44	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	45	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	46	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref13	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	47	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	48	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	49	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	50	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref14	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref14	NN
work_myfomrpabnam7f4o57fxudm5bi	148	51	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref15	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref15	JJ
work_myfomrpabnam7f4o57fxudm5bi	148	52	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref15	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref15	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	53	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref15	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref15	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	54	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	55	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	56	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref16	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	57	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref17	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref17	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	58	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref17	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref17	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	59	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref18	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref18	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	60	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref18	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref18	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	61	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref19	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref19	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	62	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref19	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref19	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	63	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	64	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	65	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref20	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	66	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref21	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref21	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	67	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref21	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref21	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	68	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref21	http://refhub.elsevier.com/s0828-282x(16)31114-x/sref21	NN
work_myfomrpabnam7f4o57fxudm5bi	148	69	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	70	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	71	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	http://refhub.elsevier.com/S0828-282X(16)31114-X/sref23	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	72	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	148	73	Rise	Rise	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	74	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	148	75	Fall	fall	NN
work_myfomrpabnam7f4o57fxudm5bi	148	76	of	of	IN
work_myfomrpabnam7f4o57fxudm5bi	148	77	Tuberculosis	Tuberculosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	78	and	and	CC
work_myfomrpabnam7f4o57fxudm5bi	148	79	Atherosclerosis	Atherosclerosis	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	80	:	:	:
work_myfomrpabnam7f4o57fxudm5bi	148	81	First	first	RB
work_myfomrpabnam7f4o57fxudm5bi	148	82	There	there	EX
work_myfomrpabnam7f4o57fxudm5bi	148	83	Is	be	VBZ
work_myfomrpabnam7f4o57fxudm5bi	148	84	a	a	DT
work_myfomrpabnam7f4o57fxudm5bi	148	85	Mountain	Mountain	NNP
work_myfomrpabnam7f4o57fxudm5bi	148	86	…	…	NFP
work_myfomrpabnam7f4o57fxudm5bi	148	87	How	how	WRB
work_myfomrpabnam7f4o57fxudm5bi	148	88	Do	do	VBP
work_myfomrpabnam7f4o57fxudm5bi	148	89	We	-PRON-	PRP
work_myfomrpabnam7f4o57fxudm5bi	148	90	Explain	explain	VB
work_myfomrpabnam7f4o57fxudm5bi	148	91	These	these	DT
work_myfomrpabnam7f4o57fxudm5bi	148	92	Improvements	improvement	NNS
work_myfomrpabnam7f4o57fxudm5bi	148	93	?	?	.
work_myfomrpabnam7f4o57fxudm5bi	149	1	The	the	DT
work_myfomrpabnam7f4o57fxudm5bi	149	2	New	New	NNP
work_myfomrpabnam7f4o57fxudm5bi	149	3	Mountain	Mountain	NNP
work_myfomrpabnam7f4o57fxudm5bi	149	4	Social	Social	NNP
work_myfomrpabnam7f4o57fxudm5bi	149	5	Deprivation	Deprivation	NNP
work_myfomrpabnam7f4o57fxudm5bi	149	6	Future	Future	NNP
work_myfomrpabnam7f4o57fxudm5bi	149	7	Directions	Directions	NNPS
work_myfomrpabnam7f4o57fxudm5bi	149	8	Disclosures	disclosure	VBZ
work_myfomrpabnam7f4o57fxudm5bi	149	9	References	reference	NNS